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INTRODUCTION 
 Among all the route of drug delivery system, drug delivery through the 
oral route is most common and preferred for both solid and liquid dosage 
forms. Solid dosage forms are more popular. Tablet is one of the preferred 
solid dosage form because of its dose, safest and economical (Adchitre 
Vaishali B et al., 2016). 
  Tablet is defined as a compressed solid dosage form containing 
medicaments with or without excipients. According to the Indian 
Pharmacopoeia, Tablets are solid, flat or biconvex dishes, unit dosage form 
prepared by compressing a drug or a mixture of drugs with or without diluents. 
They vary in shape and differ greatly in size and weight depending on the 
amount of medical substances and the intended mode of administration. All the 
medicaments are available in the tablet form except where it is difficult to 
formulate or administer. 
General properties of tablet dosage form: 
 A tablet should have elegant product identity while free of defects 
like chips, cracks, discolouration and contamination. 
 Should have sufficient strength to withstand mechanical shock 
during its production packaging, shipping and dispensing. 
 Should have the chemical and physical stability to maintain its 
physical attributes over time. 
 The tablet must be able to release the medicinal agents in a 
predictable and reproducible manner. 
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 Must have a chemical stability over time so as not to follow 
alteration of the medicinal agents. 
Use of disintegrants is the basic approach in the development of 
tablets. Disintegrants play a major role in the disintegration and 
dissolution of tablet. It is critically essential to choose a suitable 
disintegrant, in an optimum concentration so as to ensure quick 
disintegration and high dissolution rates. 
 
MECHANISM OF DISINTEGRATION (Arijit Gandhi 2012): 
 
There are four major mechanisms for tablets disintegration as follows: 
 Swelling 
 Porosity and capillary action (Wicking) 
 Disintegrating particle / particle repulsive forces 
 Deformation 
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1.Swelling:  
The most widely accepted general mechanism of action for tablet 
disintegration is swelling. Tablets with high porosity show poor disintegration 
due to lack of adequate swelling force. On the other hand, sufficient swelling 
force is exerted in the tablet with low porosity.  
   
2. Porosity and capillary action: 
Disintegration by capillary action is always the first step. When we put 
the tablet into suitable aqueous medium, the medium penetrates into the tablet 
and replaces the air adsorbed on the particles, which weakens the 
intermolecular bond and breaks the tablet into fine particles. Water uptake by 
tablet depends upon hydrophilicity of the drug /excipient and on tableting 
conditions. For these types of disintegrants maintenance of porous structure 
and low interfacial tension towards aqueous fluid is necessary which helps in 
disintegration by creating a hydrophilic network around the drug particles. 
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3. Due to disintegrating particle/particle repulsive forces: 
Another mechanism of disintegrant attempts to explain the swelling of 
tablet made with non-swellable disintegrants. Guyot-Hermann has proposed a 
particle repulsion theory based on the observation that no swelling particle also 
causes disintegration of tablets. The electric repulsive forces between particles 
are the mechanism of disintegration and water is required for it. Researchers 
found that repulsion is secondary to wicking. 
     
4.  Due to deformation: 
 During tablet compression, disintegrated particles get deformed and 
these deformed particles get into their normal structure when they come in 
contact with aqueous media or water. Occasionally, the swelling capacity of 
starch was improved when granules were extensively deformed during 
compression. This increase in size of the deformed particles produces a 
breakup of the tablet. 
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TYPES OF TABLETS: 
 Uncoated tablets 
 Coated tablets 
 Effervescent tablets 
 Soluble tablets 
 Dispersible tablets 
 Orodispersible tablets 
 Gastro-resistant tablets 
 Modified-release tablets 
 
ORODISPERSIBLE TABLETS: 
 One important drawback of oral solid dosage forms like tablet and 
capsule is disphagia or difficulty in swallowing, leading to patient incompliance 
particularly in case of pediatric, geriatric, bed ridden, nauseous patients, 
unconsciousness, motion sickness, unavailability of water and mentally 
disabled persons. Drinking water plays an important role in swallowing. 
Approximately one-third of the population (mainly pediatric and geriatric) has 
swallowing difficulties resulting in poor compliance with oral dosage form which 
results in a high incidence of non-compliance and ineffective therapy. To 
overcome these difficulties pharmaceutical technologists have devoted 
considerable efforts for developing a novel type of dosage form for oral 
administration known as orally disintegrating tablets(ODTs) (Shivam Singh et 
al., 2017). 
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 Orodispersible tablets are also called as orally disintegrating tablets, 
mouth-dissolving tablets, rapid dissolving tablets, fast-disintegrating tablets, 
fast-dissolving tablets. Recently, European Pharmacopoeia has used the term 
orodispersible tablets. This may be defined as “uncoated tablets intended to be 
placed in the mouth where they disperse readily within 3 minutes before 
swallowing”. The United States Pharmacopoeia has also approved these 
dosage forms as orodispersible tablets (Pooja Arora et al., 2013).      
 
SELECTION OF ODT DRUG CANDIDATES: (Adchitre Vaishali et al., 2016) 
 No bier taste. 
 Dose lower than 20mg. 
 Small to moderate molecular weight. 
 Good stability in water and saliva. 
 Partially non ionized at the oral cavities Ph. 
 Ability to diffuse and partition into the epithelium of the upper GIT (log 
p>1 or preferably>2). 
 Short half-life and frequent dosing. 
 
ADVANTAGES OF ODTs: (Ujjwal Nautiyal et al., 2014)  
 Ease of administration to patient who cannot swallow such as 
geriatric, pediatric, mentally disabled, stroke victims and bed-ridden 
patients, who have difficulty in swallowing the tablet. 
 The FDTs do not need water for swallowing unlike conventional 
dosage forms. This is very convenient for patients who are travelling 
or do not have immediate access to water, and thus, provide 
improved patient compliance. 
 Being unit solid dosage forms, provide luxury of accurate dosing, 
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easy portability and manufacturing, good physical and chemical 
stability and an ideal alternative for pediatric and geriatric patients. 
 Bioavailability of drugs is enhanced due to absorption from mouth, 
pharynx, and oesophagus. 
 Pregastric absorption can result in improved bioavailability and 
because of reduced dosage, improved clinical performance through a 
reduction of unwanted effects. 
 Rapid onset of therapeutic action as tablet is disintegrated rapidly 
along with quick dissolution and absorption in oral cavity. 
 Good mouth feels, especially for paediatric patients as taste-masking 
technique is used to avoid the bitter taste of drugs. 
 Minimum risk of suffocation in airways due to physical obstruction, 
when ODTs are swallowed, thus they provide improved safety and 
compliance with their administrations. 
 Rapid drug therapy intervention is possible. 
 Conventional processing and packaging equipment allow the 
manufacturing of tablets at low cost. 
 No specific packaging is required. It can be packaged in push through 
blisters. 
 Provide new business opportunities in the form of product 
differentiation, patent-life extension, uniqueness, line extension, and 
lifecycle management, and exclusivity of product promotion. 
 
DISADVANTAGES OF ODTs: (Ujjwal Nautiyal et al., 2014) 
 Drugs with relatively large doses are difficult to formulate into FDTs. 
 Patients who concurrently take anti-cholinergic medications may not 
be the best candidates for FDTs. 
 Tablets usually have insufficient mechanical strength. Hence, it 
requires careful packaging and handling. 
 Tablets may leave unpleasant taste and/or grittiness in mouth if not 
formulated properly. 
 They are more susceptible to degradation by humidity and temperature. 
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 Fast dissolving tablet is hygroscopic in nature so must be keep in dry 
place. 
 Some time it possesses mouth feeling. 
 MDT requires special packaging for properly stabilization & safety of 
stable product. 
 Drugs difficult to formulate into FDT with relatively larger doses. 
 Drugs with short half-life and frequent dosing and those whom require 
controlled or sustained release are unsuitable candidates of FDTs. 
 Eating and drinking may become restricted. 
 Light sensitive drugs, ODT’s may not be suitable as no option for film 
coating. 
 
CHALLENGES IN FORMULAION OF ODTs: (Anupam Roy et al., 2016) 
Mechanical strength and disintegration time 
ODTs are formulated to obtain disintegration time usually less than a minute. 
While doing so, maintaining a good mechanical strength is a prime challenge. 
Increasing the mechanical strength will delay the disintegration time. So, a 
good compromise between these two parameters is always essential. 
Tastes masking 
Many drugs are bitter in taste. A tablet of bitter drug dissolving/disintegration in 
the mouth will seriously affect patient compliance and acceptance for the 
dosage form. Hence, effective taste masking of the bitter drugs must be done 
so that the taste of the drug is not felt in the oral cavity. 
Aqueous solubility 
Water-soluble drugs pose various formulation challenges because they form 
eutectic mixtures, which result in freezing-point depression and the formation of 
a glassy solid that may collapse upon drying because of loss of supporting 
structure during the sublimation process. Such collapse sometimes can be 
prevented using various matrix-forming excipients such as mannitol that can 
induce crystallinity and hence, impart rigidity to the amorphous composite. 
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Size of tablets 
The degree of ease when taking tablets depends on its size. It has been 
reported that the easiest size of tablet to swallow is 7-8 mm while the easiest 
size to handle was one larger than 8 mm. Therefore, the tablet size that is both 
easy to take and easy to handle is difficult to achieve. 
Amount of drug 
The application of technologies used for ODTs is limited by the amount of drug 
that can be incorporated into each unit dose. According to USP generally, the 
ODT tablet weight should not exceed 500 mg. For lyophilized dosage form, the 
drug dose should be lower than 400 mg for insoluble drug and <60 mg for 
soluble drug. This parameter is particularly challenging when formulating a fast-
dissolving oral films or wafers. 
Hygroscopicity 
Several orally disintegrating dosage forms are hygroscopic and cannot 
maintain physical integrity under normal conditions of temperature and 
humidity. Hence, they need protection from humidity which calls for specialized 
product packaging. 
Mouth feel 
Larger particles can result in a gritty feeling the oral cavity. Thus, small particles 
are preferred. Moreover, addition of flavors and cooling agents like menthol 
improve the mouth feel. 
Good packaging design 
For the protection of ODTs from moisture and other environmental hazards, the 
package design should be considered early in the development stages. 
 
CRITERIA FOR EXCIPIENTS USED IN ODTs: (Shivam Singh et al., 2017) 
 Their individual properties should not affect the FDTs. 
 It must be able to disintegrate quickly. 
 It should not have any interaction with drug and other excipients. 
 When selecting binder (a single or combination of binders) care 
 must be taken in the final integrity and stability of the product. 
 The melting point of the excipients used should be in the range of 
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 30-35 °C. 
 It should not interfere in the efficacy and organoleptic properties 
 of the product. 
 The binder may be in liquid, semi-solid, solid or polymeric in nature. 
 
 
EXCIPIENTS USED IN FORMULATION OF ODTS: 
Excipients used in FDTs contain at least one super disintegrant, a 
diluent, a lubricant and optionally a swelling agent, a permeabilizing agent, 
sweeteners and flavouring agents. 
 
 
SUPERDISINTEGRANTS: 
Super disintegrants which are effective at low concentration and have 
greater disintegrating efficiency, and they are more effectiveintragranular. 
These superdisintegrants act by swelling and due to swelling pressure exerted 
in the outer direction or radial direction, it causes the tablet to burst or the 
accelerated absorption of water leading to an enormous increase in the volume 
of granules to promote disintegration. 
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TYPES OF SUPERDINEGRANTS: (Mohit Mangal et al., 2012) 
 The Superdisintegrants can be classified into two categories on the basis of 
their availability:  
 Natural Superdisintegrants  
 Synthetic Superdisintegrants.  
 
NATURAL SUPERDISINTEGRANTS:  
These superdisinegrating agents are natural in origin and are preferred 
over synthetic substances because they are comparatively cheaper, 
abundantly available, non-irritating and nontoxic in nature. The natural 
materials like gums and mucilages have been extensively used in the field of 
drug delivery for their easy availability, cost effectiveness, Eco friendliness, 
emollient and non-irritant nature, non-toxicity, capable of multitude of chemical 
modifications, potentially degradable and compatible due to natural origin. 
There are several gums and mucilages are available which have super-
disintegrating acvtivity. 
 
 Plantago Ovata Seed Mucilage (Isapgula)  
Isapghula consists of dried seeds of the plant plantagoovata and it 
contains mucilage which is present in theepidermis of the seeds. The seeds of 
Plantagoovatawere soaked in distilled water for 48 hrs and then boiled for few 
minutes for complete release of mucilage into water. The material was 
squeezed through muslin cloth for filtering and separating out the marc. Then, 
an equal volume of acetone was added to the filtrate so as to precipitate the 
mucilage. The separated mucilage was dried in oven at temperature less than 
60°C .The mucilage of plantagoovatais a recent innovation for its 
superdisintegration property when compared with Crospovidone. It shows 
faster disintegration time than the superdisintegrant,Crosspovidone.  
 Lepidiumsativum Mucilage  
Lepidiumsativum(family: Cruciferae) is known as asaliyo and is widely 
used as herbal medicine in India. It is widely available in market and has very 
low cost. Parts used are leaves, root, oil, seeds etc. Seeds contain 
higheramount of mucilage, dimeric imidazole alkaloids lepidine B, C, D, E and 
CHAPTER I                                                                  INTRODUCTION 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 12 
 
F and two new monomeric imidazole alkaloids semilepidinosideA and B. 
Mucilage of Lepidiumsativumhas various characteristic like 
binding,disintegrating, gelling. 
 Gum Karaya 
 Gum Karaya is a negative colloid and a complex polysaccharide of high 
molecular weight. On hydrolysis it yields galactose, rhamnose and galacturonic 
acid. Gum Karaya occurs as a partially acetylated derivative. It is a dried 
exudation of sterculiaUrenstree (Family-Sterculiaceae). Its synonyms are 
Karaya, sterculia, Indiantragacanth, Bassoratragacanth, kadaya, Kadira,katila. 
Gum Karaya is compatible with other plant hydrocolloids as well as proteins 
and carbohydrates. 
 Fenugreek Seed Mucilage  
Trigonella Foenum-graceum, commonly known as Fenugreek, is an 
herbaceous plant of the leguminous family. It has found wide applications as a 
food, a food additive, and as a traditional medicine. The leaves and both the 
ripe and unripe seeds of Trigonella Foenum-graceumare used as vegetables. 
Fenugreek has been used in treating colic flatulence, dysentery, diarrhoea, 
dyspepsia with loss of appetite, chronic cough, dropsy, enlargement of liver and 
spleen, rickets, gout, and diabetes. It is also used as gastro protective, 
antiurolithiatic, diuretic, antidandruff agent, Anti-inflammatory agent and as 
antioxidant. The seed is stated to be a tonic. It also is used in post-natal care 
and to increase lactation in nursing mothers. Fenugreek seeds contain a high 
percentage of mucilage (a natural gummy substance present in the coatings of 
many seeds). Although it does not dissolve in water, mucilage forms a viscous 
tacky mass when exposed to fluids. Like other mucilage-containing substances, 
fenugreek seeds swell up and become slick when they are exposed to fluids. 
The resulting soft mass is not absorbed by the body, but instead passes 
through the intestines and triggers intestinal muscle contractions. 
 Guar gum  
Guar gum is a galactomannan, commonly used in cosmetics, food 
products and in pharmaceutical formulations.Guar gum is mainly consisting of 
the high molecular weight (approximately 50,000-8,000,000) polysaccharides 
composed of galactomannans and is obtained from the endosperm of the seed 
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of the guar plant, Cyamopsistetragonaloba (L) Taub. (Synonym-
Cyamopsispsoraloides). It is used as thickener, stabilizer and emulsifier, and 
approved in most areas of the world (e.g. EU, USA, Japan, and Australia). Its 
synonyms are Galactosol; guar flour; jaguar gum; meprogat; meyprodor. It has 
also been investigated in the preparation of sustained release matrix tablets in 
the place of cellulose derivatives such as methylcellulose. In pharmaceuticals, 
guar gum is used in solid-dosage forms as a binder and disintegrant, and in 
oral and topical products as a suspending, thickening, and stabilizing agent, 
and also as a controlled-release carrier. Guar gum has also been examined for 
use in colonic drug delivery. 
 
 
 
 Cassia fistula gum  
Seeds of Cassia fistula gum obtained from cassia fistula tree. Gum 
obtained from the seeds of Cassia fistula comprises β-(1→4) linked d-
mannopyranose units with random distribution of _α (1→6) linked d-
galactopyranose units as side chain having mannose:galactose ratio of 3.0). 
Carboxymethylation as well as carbamoylethylation of Cassia gum is reported 
to improve cold water solubility, improve viscosity and increase microbial 
resistance as compared to native gum Therefore, an attempt was made to 
incorporate calcium or sodium salts of carboxymethylated or 
carbamoylethylated C. fistula gum as superdisintegrant in the formulation 
development of FDT. 
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 Locust Bean gum  
Locust bean gum is extracted from the endosperm of the seeds of the 
carob tree Ceretoniasiliqua, which grows in Mediterranean countries. It is also 
called Carob bean gum. Some other familiar polysacharides are starch and 
cellulose, which are made of long chains of the sugar glucose. In locust bean 
gum, the ratio of mannose to galactose is higher than in guar gum, giving it 
slightly different properties, and allowing the two gums to interact synergistically 
so that together they make a thicker gel than either one alone. It shows as a 
binder and as a disintegrant property at different concentration. Pharmaceutical 
application of locust bean gum in various novel drug delivery systems. Locust 
bean gum has been widely used in food industry as a thickening and gelling 
agent. Locust bean gum has also been reported to have bioadhesive and 
solubility enhancement properties. There are various reports that Locust bean 
gum can be used in pharmaceutical and biotechnological purpose. 
 
 
 Hibiscus rosa-sinensis Linn. Mucilage  
Hibiscus rosa-sinensis Linn of the Malvaceae family is also known as the 
shoe‐flower plant, China rose, and Chinese hibiscus. The plant is available in 
India in large quantities and its mucilage has been found to act as a 
superdisintegrant. The plant contains cyclopropanoids, methyl sterculate, 
methyl‐2‐hydroxysterculate, 2‐hydroxysterculate malvate and β‐rosasterol. The 
leaves contain carotene (7.34 mg/100 g of fresh material) moisture, protein, fat, 
carbohydrate, fibers, calcium, and phosphorus. Mucilage of Hibiscus rosa-
sinensiscontains L‐rhamnose, D‐galactose, D‐-galactouronic acid, and 
D‐glucuronic acid. 
CHAPTER I                                                                  INTRODUCTION 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 15 
 
 Mango Peel Pectin  
Dried mango peel powder is use for extracting pectin. Rather mango 
peel pectin cannot be used for promising the behaviour of superdisintegrants, 
but due to its good swelling index and good solubility in biological fluids it can 
be used to prepare fast dispersible tablets.  
 
SYNTHETIC SUPERDISINTEGRANTS: 
A group of superdisintegrants including croscamellose sodium (Ac-Di-
Sol) sodium starch glycolate (Primojeland Explotab) and crospovidone 
(Polyplasdone XL) alleviate most of these problems. Use of the 
superdisintegrants in fast dispersible tablet is possible as tablet shows optimum 
physical properties.  
Advantages of Synthetic Superdisintegrants  
 Effective in lower concentrations than starch.  
 Less effect on compressibility and flow ability.  
 More effective intragranularly 
 
 Sodium Starch Glycolate: (Explotab, Primogel)  
Sodium starch glycolate is widely used in oral pharmaceuticals as a 
disintegrant in capsule and tablet formulations. It is recommended to use in 
tablets prepared by either direct-compression or wet-granulation processes. 
The recommended concentration in a formulation is 2-8%, with the optimum 
concentration about 4% although in many cases 2% is sufficient. Disintegration 
occurs by rapid uptake of water followed by rapid and enormous 
swelling.Thedisintegrant efficiency of sodium starch glycolate is unimpaired in 
the presence of hydrophobic excipients, such as lubricants unlike many other 
disintegrants. Increasing the tablet compression pressure also appears to have 
no effect on disintegration time. These are modified starches with dramatic 
disintegrating properties and are available as explotab and primogel which are 
low substituted carboxy methyl starches. Explotabconsisting of granules that 
absorb water rapidly and swell. The mechanism by which this action takes 
place involves rapid absorption of water leading to an enormous increase in 
volume of granules result in rapid and uniform disintegration. The natural 
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predried starches swell in water to the extent of 10-20 percent and the modified 
starches increase in volume by 200-300 percent in water. 
 
 Cross-linked polyvinyl pyrrolidone: (crospovidone, 
PolyplasdoneXL, XL10) 
 Crospovidone quickly wicks saliva into the tablet to generate the volume 
expansion and hydrostatic pressures necessary to provide rapid disintegration 
in the mouth. Unlike other superdisintegrants, which rely principally on swelling 
for disintegration, Crospovidone superdisintegrants use a combination of 
swelling and wicking. When examined under a scanning electron microscope, 
crospovidone particles appear granular and highly porous. This unique, porous 
particle morphology facilitates wicking of liquid into the tablet and particles to 
generate rapid disintegration. Due to its high crosslink density, crospovidone 
swells rapidly in water without gelling. Other superdisintegrants have a lower 
crosslink density and, as a result, form gels when fully hydrated,particularly at 
the higher use levels in ODT formulations.Swells very little andreturns to 
original size after compression but act by capillary action.  
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Unlike other superdisintegrants, which rely principally on swelling for 
disintegration, Polyplasdone disintegrants use a combination of mechanisms to 
provide rapid disintegration. Although Polyplasdone polymers swell by 95% to 
120% upon contact with water, swelling is not the only mechanism for tablet 
disintegration. Swelling or swell volume is mainly a measure of the change in 
volume of the disintegrant after it is introduced to an aqueous solution and the 
system has reached equilibrium. However, swell volume does not measure the 
rate at which a disintegrant absorbs water and swells or the pressure 
generated by swelling. Polyplasdone polymers, with their porous particle 
morphology rapidly absorb water (wicking) via capillary action. As the deformed 
polyplasdone particles come in contact with water that is wicked into the tablet, 
the polyplasdone particles recover their normal structure and then swell, 
resulting in rapid volume expansion and high hydrostatic pressures that cause 
tablet disintegration.   
 
 Modified Cellulose (croscarmellosesodium, Ac-Di-Sol)  
Croscarmellose sodium is described as a cross-linked polymer of 
carboxy methyl cellulose (CMC). This polymer is different in synthesis and 
structure as compare to Sodium starch glycolate. Most importantly, the degree 
of substitution using Williamson‟s ether synthesis of croscarmellose sodium is 
higher than that of sodium starch glycolate, and the mechanism of crosslinking 
is also different. The chemistry of SSG is different that of cross carmellose 
sodium as some of  the carboxymethyl groups themselves are used to cross-
link the cellulose chains. For example, the cross-linking in Primogel are 
phosphate ester rather than carboxyl ester links as compare to Cross 
carmellose sodium. Croscarmellose sodium at concentrations up to 5% w/w 
may be used as a tablet disintegrant, although normally 2% w/w is used in 
tablets prepared by direct compression and 3% w/w in tablets prepared by a 
wet-granulation process. 
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 Resins   
Resins althoughinsoluble, have great affinity for water and hence, act 
asdisintegrant. Moreover, because of their smallerparticle size the rate of 
swelling is high making themsuperdisintegrant. Like conventional disintegrant, 
theydon‟t lump but additionally impart strength to the tablets. The use of ion 
exchange resins into drug delivery systems have been encouraged because of 
their physico-chemical stability, inert nature, uniform size, spherical shape 
assisting coating and equilibrium driven reproducible drug release in ionic 
environment. Ion exchange resins are insoluble polymers that contain acidic or 
basic functional groups and have the ability to exchange counter-ions within 
aqueous solutions surrounding them.Drug, molecules attached to the resins are 
released by appropriate charged ions in the gastrointestinal tract, followed by 
diffusion of free drug molecules out of the resins as shown below,  
Resin- Drug+ +X+…….............> Resin-....X++Drug+ 
 (1) Resin+Drug-+X-………….…..>Resin+...X-+Drug 
 (2) Where, X and Y are ions in the gastrointestinal tract . 
 
BULKING MATERIALS 
Bulking materials are important in the development of fast dissolving 
tablets. They contribute the functions of a diluent, filler and cost reducer. 
Bulking agents improve the texture of the tablets that consequently enhances 
the disintegration in the mouth, besides 
adding volume and reducing the concentration of the active in the formulation. 
The bulking agents for this dosage form should be more sugar-based such as 
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mannitol, polydextrose, lactose derivatives such as directly compressible 
lactose (DCL) and starch hydrolysate for 
higher aqueous solubility and good sensory perception. Mannitol especially has 
high aqueous solubility and good sensory perception, as it provides a cooling 
effect due to its negative heat of solution. Bulking agents are added in the 
range of 10% to about 90% by 
weight of the final composition. The descending order of brittleness of 
excipients is ranked as microcrystalline cellulose>alpha lactose 
monohydrate>spray-dried lactose>anhydrous beta lactose>anhydrous alpha 
lactose>> dicalcium phosphate dihydrate. The commonly used sugar-based 
excipients are especially bulking agents (like dextrose, fructose, lactitol, 
maltitol, maltose, mannitol, sorbitol, starch hydrolysate, polydextrose and 
xylitol) which exhibit high aqueous solubility and sweetness thereby contribute 
taste masking property and provide pleasant mouth feel. Sugar based 
excipients can be of types on the basis of moulding and dissolution rate: 
Type 1 saccharides: (lactose and mannitol) which exhibit low 
moldability but high dissolution rate. 
Type 2 saccharides: (maltose and maltitol) which exhibit high 
moldability but low dissolution rate. 
 
EMULSIFYING AGENTS 
Emulsifying agents are significant for formulating fast dissolving tablets 
as they help in quick disintegration and drug release without the need for 
chewing, swallowing or drinking water. Also, emulsifying agents stabilize the 
immiscible blends and increase bioavailability. A variety of emulsifying agents 
for fast dissolving tablet formulations include alkyl sulfates, propylene glycol 
esters, lecithin, sucrose esters and others. These can be added in the range of 
0.05% to about 15% by weight of the final formulation. 
 
LUBRICANTS 
Though not essential excipients, these can aid in making the 
tabletsmore palatable after they disintegrate in the mouth. Lubricants reduce 
grittiness and help in the drug transit process from the oral to the stomach. 
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FLAVOURS (TASTE MASKING AGENTS) AND SWEETENERS 
Flavours and taste masking agents make the products more palatable 
and pleasing for patients. The incorporation of these ingredients assists in 
overcoming bitterness and undesirable tastes of some actives. Natural as well 
as synthetic flavours can be used to 
enhance the organoleptic characteristic of fast dissolving tablets. A wide range 
of sweeteners including sugar, dextrose and fructose, as well as non-nutritive 
sweeteners such as aspartame, sodium saccharin, sugar alcohols and 
sucralose are available. The addition of sweeteners imparts a pleasant taste as 
well as bulk to the formulation. 
 
TECNOLOGIES USED TO MANUFACTURE ODTs: 
COVENTIONAL TECHNOLOGY: (Shivam Singh 2017) 
1.Freeze-drying or lyophilization 
It is a pharmaceutical process that allows the drying of heat sensitive 
drugs and biological under low temperature by the application of vacuum to 
remove water by sublimation. Drugs are dissolved or dispersed in aqueous 
solution of a carrier, transferred 
to preformed blister packs and subjected to nitrogen flush to freeze out, then 
placed in the refrigerator to complete the process. Characteristics of 
lyophilization techniques are, they possess high porosity and specific surface 
area, and gets dissolve rapidly in mouth presenting high drug bioavailability. 
The major drawback of this system is high cost, time-consuming procedure and 
fragility, making conventional packing inappropriate for packing this dosage 
form and stability issues under stress condition. 
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Advantages 
The major advantage of using this technique is that the tablets produced 
by this technology have very low disintegration time and have great mouthfeel 
due to fast melting effect. 
 
2.Moulding method 
Tablets are designed using hydrophilic ingredients, with the aim to get 
maximum drug dissolution. Powder mass is wetted with hydroalcoholic solvent 
and compressed into a dosage form. The solvent system is then allowed to 
evaporate. Taste of drug particles is developed by spray congealing the molten 
mixture of hydrogenated cottonseed oil, sodium carbonate, lecithin, polyethene 
glycol with an active ingredient into lactose based tablet triturate. 
Characteristics of moulding method are, very porous as solvents are removed 
by drying leaving porous mass which promotes rapid dissolution. 
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3.Melt granulation 
Melt granulation technique is a process by which the pharmaceutical 
powders are capably agglomerated by a meltable binder. The benefit of this 
technique compared to a conventional granulation is that no water or organic 
solvents is required. Since there is no drying step, the process is less time 
consuming and requires less energy than wet granulation. It is a technique 
useful to enhance the dissolution rate of poorly water-soluble drugs, such as 
griseofulvin. 
4.Mass-extrusion 
In this the mixed ingredients are softened by water soluble ingredient i.e. 
polyethene glycol, using methanol as solvent, passing through an extruder to 
form thin cylinders. Which further get sliced with a heated blade to form small 
tablets. Characteristics of this method is these products can be used to mask 
bitter tasting drugs 
making small granules thus enhancing oral bioavailability. 
5.Sublimation 
Rapid disintegration and dissolution is acquired by formulating into 
porous mass by incorporating inert solid ingredients that volatilize rapidly like 
urea, camphor ammonium carbonate, ammonium bicarbonate and 
hexamethylene-tetramine. They were mixed with 
other ingredients and compressed. The volatile material is evolved by reduced 
pressure and applying slight temperature leaving the mass in porous form. 
Characteristics of sublimation method are, they are porous in nature, solvents 
like cyclohexane and benzene can be used. 
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6.Direct compression 
The disintegrant addition technology (direct compression) is the most 
preferred technique to manufacture the tablets due to certain advantages: 
 High doses can be accommodated and final weight of the 
tablet can exceed that of other methods. 
 The easiest way to manufacture the tablets. 
 Conventional equipment and commonly available 
excipients are used. 
 A limited no. of processing steps are involved. 
 Cost effectiveness. 
Tablet size and hardness strongly affect the disintegrant efficacy. Hard 
and large tablets have more disintegration time than normally required. Very 
soft and small tablets have low mechanical strength. So, an optimum kind and 
concentration of disintegrant should be chosen to achieve quick disintegration 
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and high dissolution rates. Above the critical concentration level, however, 
disintegration time remains approximately constant or even increases. 
 
7. Cotton candy process  
This process is so named as it utilises a unique spinning mechanism to 
produce a floss-like crystalline structure, which mimics cotton candy. Cotton 
candy process involves the formation of Matrix of polysaccharides or 
saccharides by the simultaneous action of flash melting and spinning. The 
matrix formed is partially recrystallized to have improved flow properties and 
compressibility. This candy floss matrix is then milled and blended with active 
ingredients and excipients and subsequently compressed to FDTs. However, 
other polysaccharides such as poly maltodextrins and polydextrose can be 
transformed into fibers at 30-40% lower temperature than sucrose. This 
modification permits the safe incorporation of thermolabile drugs into the 
formulation. The tablets manufactured by this process are highly porous in 
nature and offer very pleasant mouth feel due to fast solubilization of sugars in 
the presence of saliva. 
8. Spray-drying 
By this method, ingredients are integrated by hydrolyzed and 
nonhydrolyzed gelatins as supporting agents, mannitol as bulking agent, 
sodium starch glycolate or crosscarmellose sodium as disintegrating and an 
acidic material (e. g. citric acid) and or alkali material (e. g. sodium bicarbonate) 
to enhance disintegration and dissolution. Characteristics of the spray-drying 
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method is this method gives rapid dissolution (within 20 seconds) when dosage 
form gets in contact with the aqueous medium. 
 
9.Phase transition process 
This processes for the disintegration of FDTs by phase transition of 
sugar alcohols using erythritol (melting point 122 °C), xylitol (93-95 °C), 
trehalose (97 °C), and mannitol (166 °C). Tablets were produced by 
compressing a powder containing two sugar alcohols with high and low melting 
points and subsequent heating at a temperature between their melting points. 
Before the heating process, the tablets do not have sufficient hardness 
because of low compatibility. The tablet hardness was increased after heating, 
due to the increase of interparticle bonds or the bonding surface area in tablets 
induced by phase transition of lower melting point sugar alcohol.  
PATENTED TECHNOLOGY: (Kushagra Khanna 2016) 
1. Zydis Technology 
Zydis formulation is a unique technology of preparing fast dissolving 
tablet. It is freeze dried tablet technology in which drug materials are physically 
entrapped or dissolved within the matrix of fast dissolving carrier materials. 
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Water is not required for swallowing because when “zydis unit” is put in mouth 
then the freeze dried structure disintegrates rapidly. Zydis material is composed 
of so many substances to achieve a number of objectives. To provide strength 
during handling polymers such as dextran, alginate and gelatin are 
incorporated. Saccharides such as sorbitol or mannitol are incorporated to 
obtain good elegance, hardness and crystallinity. To prevent the shrinkage of 
“zydis unit” during freeze drying process or long term storage glycine is 
generally used as collapse protectants. To protect the formulation from the 
moisture it should be packed in a blister. 
2. Durasolv Technology 
It is patented technology of CIMA LAB(US patent no.6,024,981) and is 
based on direct compression technology which uses suitable excipients with 
improved properties, especially superdisintegrants that accelerate the rate of 
disintegration and hence dissolution. This technology is based on employment 
of conventional non-direct compression fillers (such as dextrose, mannitol, 
sorbitol etc) in the form of fine particles that quickly dissolve without producing 
a gritty or sandy sensation in the mouth. The water soluble and sometimes 
effervescent agents can also be use that assist in the disintegration process. 
The DuraSolv® technology is designed to provide stronger tablets without 
packaging precautions and can be packed in blisters. In this technology the 
tablet consists of drug materials, lubricants and fillers.   
3. Orasolv Technology 
CIMA LAB has developed Orasolv technology. Orasolv is an 
effervescent direct compression tablet that disperses in mouth's saliva with the 
aid of almost hardly noticeable effervescence and dissolves in less than one 
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minute, leaving the coated drug powder. The unpleasant flavor of the drug is 
addressed by coating of the drug powder and effervescence. The major 
disadvantage of Orasolv is its mechanical strength due to light compression. In 
Flash dose technology the matrices are prepared by flash heat processing. 
This technique is patented by fuisz. E.g:Nurofen is the first commercial product 
by this technology launched by BiovilCorporation. 
4. Wow Technology 
It is patented by Yamanouchi Pharmaceutical Corporation where wow 
tends for “without water”. In this process high mouldability saccharide like 
oligosaccharide, mannitol is mixed with low mouldability saccharide like 
glucose, lactose and mannitol to obtain rapidly melting strong tablet. 
5. Shearform Technology 
The core of this technology is preparation of floss. Floss is prepared by 
subjecting feed stock containing sugar carrier to flash heat process. Sucrose 
plus either mannitol or dextrose is mixed with surfactant and blended well. This 
is the primary floss mixture. In flash heat process, the carrier materials show an 
internal flow condition, which is heat induced and exits via spinning head, and 
simultaneously under centrifugal force, the floss is flinged.The floss produced 
by the above way are longer fibers and are further chopped converting them 
into smaller particles via a high shear mixer granulator. Recrystallization is 
completed by use of ethanol treatment (1%), spraying out floss, which 
subsequent evaporation, which increases flow and cohesive properties. This 
recrystallized matrix is then mixed with drugs and other excipients and 
subjected to compression. Tablets produced by this process are highly porous, 
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have a good mouth feel, and have an immediate solubilisation of sugar as it 
comes in contact with saliva. 
6. Flashdose Technology 
This technology is much like cotton candy, using a unique spinning 
mechanism to produce crystalline floss structure. The drug can then be 
incorporated into this crystalline sugar and compressed into a tablet. Such 
product has a high surface area for dissolution, dissolving rapidly on tongue 
and easy dispersion. The Flash dose tablets consist of self–binding shear form 
matrix termed as “floss”. 
7. Ceform Technology 
The crux of this process is placing a dry powder containing pure drug 
and excipients into a rapidly spinning machine. Centrifugal force of the rotating 
head of this ceform machine, through small heated opening at high speed 
blends dry drug powder. This drug blend is liquefied to form a sphere, owing to 
the microburst of heat attained by carefully controlled temperature. This does 
not affect the stability of the drug. In the preselected oral dosage format the 
microspheres are blended and/or compressed. 
8. Flashtab Technology 
sThis technology aims to make the drug have rapid release in GIT, micro 
encapsulated drug with effervescence, and easily flash dispersal tablet. Usually 
the polymer used is Eudragit for rapid release. This technology uses 
conventional approach of wet/dry granulation follow by classical method of 
compression. Micro-granules of drug, taste masking agents, disintegrating 
agent, and swelling agents are used to formulate drugs. These tablets have 
good physical resistance, and highly suggested for hygroscopic materials for 
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blister packing as materials like polyvinyl chloride/aluminum foils cater better 
moisture protection in comparison to conventional polyvinyl chloride or 
polypropylene foils. 
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LITERATURE REVIEW 
 Ramanji Reddy et al., (2018), developed and optimized oral 
disintegtrating tablets of model drug (Lamotrizine) to give quick onset of action by 
rapidly disintegrating in a few seconds without the need of water with better patient 
compliance. By performing compatibility studies by IR spectrophotometry, no 
interaction was confirmed. Oral disintegrating tablets were formulated by direct 
compression method and evaluated by UV-Visibile spectrophotometer. Prior to 
compression, the blend of drug and excipients were evaluated for flow properties 
such as Angle of repose, Bulk density, Tapped density, % Compressibility, and 
Hausner ratio. All the formulation showed excellentproperties. Oral disintegrating 
tablets were prepared by direct compression technique using CADMACH 16 
station tablet punching machine, equipped with round flat punches of 8 mm 
diameter. Post compression evaluation of prepared oral disintegrating tablets were 
carried out with the help of different pharmacopoeial and non-pharmacopoeial 
(industry specified) tests. The shape and color of all the formulations were found to 
be circular and white in color. The thickness was found to be uniform in specific 
formulations. The hardness and friability are also within the permitted limits. 
Dissolution of tablets was carried out. The crospovidone used formulation gave the 
more dissolution profile compared to other superdisintegrants. 
Jujjuru Naga Suresh e al., (2018), Objective: The main objective of 
present research investigation is to formulate the Pravastatin Fast Dissolving 
tablets. Pravastatin. The tablets were prepared employing various concentrations 
of Crospovidone and Croscarmellose sodium in different combinations as a 
Superdisintegrants by Direct Compression technique using 32 factorial design. The 
concentration of Crospovidone and Croscarmellose sodium was selected as 
independent variables, X1 and X2 respectively whereas, wetting time, 
Disintegration time, t50 ,t90% were selected as dependent variables. the prepared 
formulations were evaluated for hardness, friability, thickness, Assay, Wetting 
time, Disintegration time, In-vitro drug release. From the Results concluded that all 
the formulation were found to be within the Pharmacopoeial limits and the In-vitro 
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dissolution profiles of all formulations were fitted in to different Kinetic models, the 
statistical parameters like intercept (a), slope (b) & regression coefficient (r) were 
calculated. Polynomial equations were developed for Wetting time, Disintegration 
time, t50%, t90%. Validity of developed polynomial equations were verified by 
designing 2 check point formulations (C1, C2). According to SUPAC guidelines the 
formulation (F1) containing combination of 8% Crospovidone and 8% 
Croscarmellose, is the most similar formulation (similarity factor f2= 89.724, 
dissimilarity factor f1= 1.307 & No significant difference, t= 0.0465) to marketed 
product (PRAVACHOL-40). The selected formulation (F5) follows First order, 
Higuchi’s kinetics, mechanism of drug release was found to be Non- Fickian 
Diffusion Super Case-II Transport (n= 1.875). 
Chinmaya Keshari Shahoo et al., (2018), formulated fast dissolving 
tablets (FDT) of carvedilol by wet granulation method was using super disintegrant 
crospovidone. Pre compression parameters, post compression parameters, 
wetting time, in vitro dispersion time, and in vitro dissolution study were evaluated 
for developed formulation. Compatibility studies of formulations were determined 
by Fourier Transform Infrared Spectroscopy (FTIR). CP4 formulation showed 
maximum 91.67 % of drug release at the end of 40 minutes among all 4 
formulations. From the FTIR study showed that there were no drug excipient 
interactions for developed formulation. It was observed that dissolution profile of 
carvedilol is more in CP4 batch as it contains more amount of crospovidone. 
 
Gabriel Marcelin-Jimenz et al., (2018), formulated the  orodispersible 
tablet (ODT) of mementine  and its bioavailability and taste acceptability were 
evaluated. In vitro characterization of ODT comprised dispersion in simulated 
saliva prior to dissolution assay in a limited volume of biorelevant media. A single 
oral dose of 20-mg memantine ODT exhibits similar bioavailability to that of an 
immediate release 20-mg tablet in a healthy population under fasting conditions. 
90% confidence interval for Cmax was of 96.78–106.52% and 98.27–104.78% for 
AUC0–72. An applied palatability survey showed exceptional acceptance of the 
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formulation. Memantine microspheres prepared by a solid-dispersion technique 
results in ODT with adequate biopharmaceutical performance. 
 
Shravan Kumar Yamsani et al., (2018), formulated and evaluated oral 
disintegrating tablets (ODTs) of etodolac to achieve rapid dissolution, absorption 
and further improving the bioavailability of the drug. The oral disintegrating tablets 
were prepared by using Croscarmellose sodium, Sodium starch glycolate and 
Crospovidone in different concentrations by direct compression method. The 
prepared tablets were evaluated for weight variation, thickness, hardness, friability, 
drug content, in vitro disintegration time, wetting time, water absorption ratio, and 
in vitro dissolution studies. Total nine formulations were prepared (i.e. F1 to F9), 
out of which tablets with F9 formulation containing 9% crospovidone showed faster 
disintegration within 15.05 seconds. 
 
Akanksha Sharma et al., (2018), developed febuxostat fast disintegrating 
tablets with fast release characteristics. Drug and beta cyclodextrin complexes 
were prepared in the ratio 1:1 and 1:2. Studies show that solubility was better for 
1:2 ratio (855.20 μg/ml) as compared to that of pure drug (10.50 μg/ml). Tablets 
were prepared by using ingredients such as Beta-Cyclodextrin, Crospovidone, 
Locust Bean Gum, Crosscarmellose, Microcrystalline Cellulose, Mannitol, 
Magnesium Stereate, Sodium Saccharine. 
 
 Pilli Rohini et al.,(2017), developed Rosuvastatin Calcium Orodispersible 
tablets by exploiting the solubilizing effect of β-cyclodextrin (β-CD). Drug–CD 
complex systems, prepared by different techniques, Precipitation method, 
Kneading method, and Co-evaporation method, they were characterized by 
Fourier transform infrared (FT-IR) spectroscopy. The inclusion complex containing 
RST: β-CD (1:1) was formulated into tablets using superdisintegrants like sodium 
starch glycolate, Crosspovidone and Crosscarmellose. Tablets containing RST- β-
CD inclusion complex were prepared by direct method and evaluated for various 
post compression parameters like hardness, friability, weight variation, thickness, 
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drug content and in-vitro dissolution. A significant improvement of the drug 
dissolution profile was achieved from tablets containing drug–CD systems 
Kneading method products showed the best dissolution profiles, reaching more 
than 97.05% drug release at the end of 30 min.  
 
Sheetal Buddhadev et al., (2017), prepared the fast dissolving tablets of 
Albendazole.  In this study, an attempt was made to fasten the drug release from 
the oral tablets by incorporating the superdisintegrant and camphor/ammonium 
bicarbonate as subliming agents. The prepared tablets were subjected to pre 
compression analysis and evaluated for hardness, weight variation, friability, 
wetting time, water absorption ratio and disintegration time. From the results of in 
vitro drug release studies, the formulation F9 exhibited fast release profile of about 
98.20% in 16 min and disintegration time 65.60 sec when compared with other 
formulations. For the optimized formulation F9, the initial dissolution rate was 
36.5% / 2 min. Fourier transform infrared spectroscopy studies revealed that there 
was no possibility of interactions between drug and excipients. The present study 
demonstrated potential for rapid absorption, improved bioavailability, effective 
therapy and patient compliance. 
 
Rao Baratam et al.,(2017), formulated and evaluated fast disintegrating 
tablets of ondansetron by direct compression method employing natural polymers 
and modified starches as super disintegrating agents. In the present study an 
attempt has been made to prepare fast Disintegrating tablets of Linseed, Isapgol, 
Sodium starch glycolate and Pregelatinized starch used in the level of addition to 
increase the rate of drug release from dosage form to increase the dissolution 
rate. Direct Compression method was used to formulate the tablets. All the 
formulations were showed the acceptable flow properties and the pre compression 
parameters like Bulk density, Tapped density and Carr’s compressibility index and 
Hausner ratio. The post compression parameters like Weight variation, friability, 
hardness, disintegration, wetting time, water absorption ration, and In vitro 
dissolution profile values were found to be within specified limits. FTIR Studies 
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shows no interaction between Drug and excipients. From the data obtained, it is 
observed from the formulation containing Isapgol in Formulation F9, shows 
Disintegration time in 12 seconds and the Percentage drug release is of 99.10% at 
the end of 30 min which satisfied all the tablet evaluation parameters for fast 
disintegrating tablet. 
 
Raghavendra Kumar Gunda et al.,(2017), prepared the Fast Dissolving 
Tablets of Moxifloxacin.HCl employing different concentrations of Crospovidone 
and Croscarmellose sodium in different combinations as a Superdisintegrants by 
Direct Compression technique using 32 factorial design. The concentration of 
Crospovidone and Croscarmellose sodium was selected as independent variables, 
X1 and X2 respectively whereas, wetting time, Disintegration time, t50%, and 
t90%were selected as dependent variables. Totally nine formulations were 
designed and are evaluated for hardness, friability, thickness, Assay, Wetting time, 
Disintegration time, In-vitro drug release. From the Results concluded that all the 
formulation were found to be with in the Pharmacopoeial limits and the In-vitro 
dissolution profiles of all formulations were fitted in to different Kinetic models, the 
statistical parameters like intercept (a), slope (b) & regression coefficient (r) were 
calculated. Polynomial equations were developed for Wetting time, Disintegration 
time, t50%, t90%. Validity of developed polynomial equations were verified by 
designing 2 check point formulations (C1, C2). According to SUPAC guidelines the 
formulation (F5) containing combination of 7.5% Crospovidone and 7.5% 
Croscarmellose, is the most similar formulation (similarity factor f2=68.88, 
dissimilarity factor f1= 3.35& No significant difference, t= 0.00354) to marketed 
product (AVELOX-400). The selected formulation (F5) follows First order, 
Higuchi’s kinetics, mechanism of drug release was found to be Non-Fickian 
Diffusion Super Case-II Transport (n= 1.902). 
 
Ranabir Chanda et al., (2017), developed mouth dissolving tablets of 
mirtazapine. Mirtazapine, vivasol, explotab, camphor, magnesium stearate, talc, 
microcrystalline cellulose were used for the preparation of the tablets. The tablets 
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were prepared by direct compression method and bulk density, tapped density, 
angle of repose, carr’s index, hausners ratio, weight variation, thickness, 
hardness, friability and in vitro drug release were evaluated. Formulation F6 was 
considered as optimized formulations for mouth dissolving tablet of mirtazapine. 
 
Sandhya V et al., (2017), developed fast disintegrating tablets of 
Selegiline, using sodium starch glycolate, cross povidone and cross carmellose 
sodium as super disintegrating agents to enhance the solubility and dissolution 
rate of drug molecule. Formulations were prepared by direct compression method 
using 6mm punch on 8 station rotary tablet punching machine. The blend of all the 
formulations showed good flow properties such as angle of repose, bulk density 
and tapped density. The prepared tablets have shown good post compression 
parameters and they passed all the quality control evaluation parameters as per IP 
limits. Among all the formulations F2 formulation showed maximum percentage 
drug release i.e., 97.26 % in 45 min, hence it is considered as optimized 
formulation. The F2 formulation contains SSG as super disintegrate in the 
concentration of 24mg. 
 
 Dr Bharathi B et al., (2016), developed and evaluated of orodispersible 
tablets of oseltamivir phosphate. The tablets were prepared by direct compression 
method using super disintegrants like crospovidone; crosscaramellose sodium; 
sodium starch glycolate. The FTIR studies results indicated that there was no in-
situ interaction between oseltamivir and the selected excipients. Based on the in 
vitro disintegration time, formulations F10, F11 and F12 were found to be 
promising and displayed in vitro dispersion time of 16, 18 and 27 sec respectively. 
 
Kamalinder K singh et al., (2016), developed and evaluated 
orodispersible sustained release tablet (ODT-SR) of domperidone, which has the 
convenience of ODT and benefits of controlled release product combined in one. 
The technology comprised of developing sustained release microspheres (MS) of 
domperidone, followed by direct compression of MS along with suitable excipients 
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to yield ODT-SR which rapidly disperses within 30 seconds and yet the dispersed 
MS maintain their integrity to have a sustained drug release. The particle size of 
the MS was optimized to be less than 200 μm to avoid the grittiness in the mouth. 
The DSC thermograms of MS showed the absence of drug-polymer interaction 
within the microparticles, while SEM confirmed their spherical shape and porous 
nature. Angle of repose, compressibility and Hausner’s ratio of the blend for 
compression showed good flowability and high percent compressibility. The 
optimized ODT-SR showed disintegration time of 21 seconds and matrix controlled 
drug release for 9 h. Invivo pharmacokinetic studies in Wistar rats showed that the 
ODT-SR had a prolonged MRT of 11.16 h as compared 3.86 h of conventional 
tablet. The developed technology is easily scalable and holds potential for 
commercial exploitation. 
 
Arifa Begum Shaik et al., (2016), formulated and developed the patient 
friendly pantoprazole sodium fast dissolving tablets using sublimation method to 
achieve rapid dissolution. In this study, an attempt was made to fasten the drug 
release from the oral tablets by incorporating the superdisintegrants and 
camphor/ammonium bicarbonate as subliming agents. The prepared fast 
dissolving tablets were subjected to pre compression analysis and evaluated for 
hardness, weight variation, friability, wetting time, water absorption ratio and 
disintegration time. From the results of in vitro drug release studies, the 
formulation F9 exhibited fast release profile of about 95.21% in 14 min and 
disintegration time 90 sec when compared with other formulations. For the 
optimized formulation F9, the initial dissolution rate was 38.82% / 2 min. Fourier 
transform infrared spectroscopy studies revealed that there was no possibility of 
interactions between drug and excipients. The present study demonstrated 
potential for rapid absorption, improved bioavailability, effective therapy and 
patient compliance. 
  
Raghavendra Kumar Gunda et al., (2016), formulated the Risperidone 
Fast Dissolving tablets. The Fast Dissolving tablets of Risperidone were prepared 
CHAPTER                                                          II LITERATURE REVIEW 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 37 
 
employing different concentrations of Crospovidone and Croscarmellose sodium in 
different combinations as a Superdisintegrants by Direct Compression technique 
using 32 factorial design. The concentration of Crospovidone and Croscarmellose 
sodium was selected as independent variables, X1 and X2respectively whereas, 
wetting time, Disintegration time, t50% ,t90%were selected as dependent 
variables. Totally nine formulations were designed, preapred and are evaluated for 
hardness, friability, thickness, Assay, Wetting time, Disintegration time, In-vitro 
drug release. From the Results concluded that all the formulation were found to be 
within the Pharmacopoeial limits and the In-vitro  dissolution profiles of all 
formulations were fitted in to different Kinetic models, the statistical parameters 
like intercept (a), slope (b) & regression coefficient (r) were calculated. Polynomial 
equations were developed for Wetting time, Disintegration time, t50%, t90%. 
Validity of developed polynomial equations were verified by designing 2 check 
point formulations (C1, C2). According to SUPAC guidelines the formulation (F5) 
containing combination of 10% Crospovidone and 10% Croscarmellose, is the 
most similar formulation (similarity factor f2= 93.556, dissimilarity factor f1= 0.976& 
No significant difference, t= 0.022) to marketed product (RISPERDAL-4). The 
selected formulation (F5) follows First order, Higuchi’s kinetics, mechanism of drug 
release was found to be Fickian Diffusion (n= 0.383). 
  
Kasar S A et al., (2016), prepared mouth dissolvingtablet of 
Metoclopramide HCl. Metoclopramide HCl is acting through its prokinetic action 
increasing gastric emptying. The tablets were prepared by direct compression 
method using 32 factorial designs. Croscarmellose sodium & crospovidone were 
used as super disintegrants. The tablets were evaluated for weight variation, 
friability, disintegration time, hardness, wetting time and drug release study. The 
tablets combination of both croscarmellose sodium and crospovidone showed 
good results for weight variation, friability, hardness, disintegration time and drug 
release study. 
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Jeevitha M et al., (2016), formulated orodispersible tablets of memantine 
hydrochloride to increase its bioavailability. Orodispersible tablets were prepared 
by direct compression technique using sublimation approach. The prepared 
powder mixtures were subjected to both pre and post compression evaluation 
parameters including; micromeritics properties, tablet hardness, friability, wetting 
time, disintegration time and in vitro drug release. The results of micromeritics 
studies revealed that all formulations were of acceptable to good flowability. Tablet 
hardness and friability indicated good mechanical strength. The F9 formulation 
which is having high concentration of camphor was given promising results for 
tablet disintegration, wetting time and gives faster dissolution rate. This increase in 
the dissolution rate may be due to the presence of crospovidone which is used as 
a superdisintegrant. This work is helped in understanding the effect of formulation 
processing variables especially the subliming agent on the drug release profile. 
 
Thirumalesh Naik S B et al., (2016), formulated the orodispersible tablets 
(ODTs) of Olanzapine (OLZ) by direct compression method for the enhancement 
of dissolution rate. OLZ ODTs were prepared by direct compression method using 
co-processed superdisintegrants like sodium starch glycolate (SSG) and 
Croscarmellose sodium (CCS). It was observed from the evaluation studies that 
the results were complied with the official limits. In-vitro dissolution studies were 
carried out by USP dissolution apparatus, paddle method using pH 6.8 phosphate 
buffer and the formulations F8, F9 showed maximum drug release of 101.16% and 
99.45% respectively within 2 min. It was evident from the drug release studies that 
the formulation F8 and F9 consists of CP-3 showed optimum drug release of 
101.80% and 100.33% respectively. 
 
Jitender Mor et al., (2016),   formulated fast dissolving tabletes of Losartan 
potassium by preparing its kneading mixture with crosspovidone. In the first step 
crosspovidone was examined for suitability as solubility enhancer in kneading 
method. The characteristics of different kneading mixture samples were compared 
to the respective physical mixtures and active pharmaceutical ingredient to access 
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the effect of various processes. Further it was evaluated which technique is better. 
The solid state of kneading mixture was evaluated with infrared spectroscopy and 
was correlated with in-vitro dissolution behavior.  
 
Prerana Mishra et al., (2016), prepared Fast Dissolving Tablets of 
nicorandil  by direct compression techniques using various concentrations of 
sodium starch glycolate, croscarmellose sodium, and crospovidone (CP) as 
superdisintegrants. The optimized batch of fast dissolving tablets of nicorandil 
were characterized for hardness, friability, in vitro disintegration, dissolution, 
stability studies. In comparison to marketed immediate-release formulation, the 
formulation (F9) was found to be faster in drug release profile as well as short 
disintegration time. The formulation F9 were found to be stable in 6 months 
stability studies in different packing. The results concluded that amongst all the 
formulations, the formulation containing CP as a superdisintegrant show faster 
disintegration and dissolution rate. 
 
Geetha K e al., (2016), formulated fast dissolving tablets of Ramipril was 
design with a view to and provide a quick onset of action. The main objective of 
the study was to formulate fast dissolving tablets of Ramipril to achieve a better 
dissolution rate and further improving the bioavailability of the drug. Fast dissolving 
tablets prepared by direct compression and using superdisintegrants in different 
concentration and evaluated for the pre-compression parameters. The prepared 
tablets were evaluated for post compressional evaluation. Among all the 9 
formulations the best formulation is with 8 % of crospovidone (CP) showed faster 
disintegration time within 11sec when compared to the other formulations and it 
showed 98.6 % drug release at the end of 30 minutes. 
 
Sandhyarani G et al., (2016), prepared orodispersible tablets of 
domperidone.domperidone drug taste was masked with Amberlite IRP 64 (1:3) 
effectively. Formulations F1,F2,F3,F4,F5,F6 and F7 are formulated with different 
concentrations of superdisintegrents by direct compression technique. Formulation 
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F5 with crosscaramellose and crospovidone with 2mg, 2mg respectively showed 
better Water absorption ratio 76.73±2.88%, wetting time 26.66±2.08 sec and 
disintegration time 25±1.0 sec. By considering disintegration time and dissolution 
time (102.85±0.23 min.) and other evaluation parameters F5 considered as 
optimized formula for comparision study with marketed Respiridone conventional 
tablet 38.02% drug released. 
 
Dr Hitesh P Dalvadi et al., (2016), formulated the orodispersible tablets of    
Amisulpride.The tablets were prepared by using direct compression method, and 
drug solubility is enhanced by solid dispersion. Formulation were prepared by 
using different superdisintegrant, combination of different superdisintegrant and 
effect of hydrophilic lubricant was studied and evaluated pre and post compression 
parameters. Tablets were evaluated for content uniformity, Disintegration time, 
wetting time, hardness, friability and In-vitro dissolution studies. More than 90% of 
drug was released from almost all the formulations within 10 min. Formulation C4 
containing Sodium starch glycolate (4.5%), Crospovidone (2.5%) and 
crosscarmellose sodium (3.5%), was having disintegration time 24 seconds, 
wetting time 18 seconds, hardness 3.4Kg/cm2 and in vitro drug release of 99.96% 
in pH 6.8. Based on this data C4 was found to be the best formulation. Further 
formulations were subjected to accelerated stability studies. Tablets showed no 
appreciable changes with respect to disintegration and dissolution profiles. Results 
of this study indicate among the superdisintegrants tried, combination of 
superdisintegrant gave the best result. 
 
Kamala Kumari P V et al., (2015), formulated oral disintegrating tablets of 
amlodipine besylate with a view to achieve a better disintegration and dissolution 
rate and further improving the bioavailability of the drug and increase the 
convenient means of administration to those patients suffering from angina 
pectoris. Oral disintegrating tablets (ODT) of Amlodipine besylate using natural 
superdisintegrants, synthetic superdisintegrants and coprocessed excipients were 
prepared by direct compression method. The superdisintegrants used in the study 
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were crosspovidine and fenugreek seed powder in varying concentrations.2 The 
prepared tablets were evaluated for pre and post compression parameters such as 
flow properties, hardness, friability, disintegration time, wetting time, estimation of 
drug content and in vitro drug release studies. The optimized formulation showed 
the minimum disintegration time of 16 secs and release maximum amount of drug 
in 30 min. Short term stability studies indicated no significant changes in hardness, 
friability, in vitro disintegration time, drug content and in vitro drug release. 
  
  Anirudha V Munde et al., (2015), prepared Lansoprazole orodispersible 
tablets were by direct compression method using varying concentrations of 
Croscarmellose sodium, Sodium Starch Glycolate, Crospovidone as 
superdisintegrants. The formulations prepared were evaluated for various 
parameters like, hardness, weight variation, Friability, in vitro dispersion time, 
water absorption ratio, drug content uniformity and in vitro drug release. The 
tablets prepared were dispersed in the range of 8.3±0.6-23.7±1.5seconds, the 
water absorption ratio was 24.9±4.2-186.8±3.2% and the drug was uniformly 
dispersed in all the formulations in the range of 95.6±0.4-102.5±0.8%. Among the 
formulation prepared the tablet containing 7.5% of Crospovidone 99.736±0.763% 
of the drug within 18 min. The overall result indicated that the formulation F6 
containing Crospovidone 7.5% is better and fulfilling of the needs of the 
orodispersible tablets. 
  
Himansu Bhusan Samal et  al., (2015),  formulated, Evaluated and 
optimized fast dissolving tablets of Glimepiride. Glimepiride is a Third generation 
sulphonylureas used for the treatment of type-2 diabetes and belongs to BCS 
class II drugs (Low Solubility and High Permeability). Glimepiride was the drug of 
choice because of its low dose. Glimepiride fast dissolving tablets (F1- F18) were 
prepared using superdisintegrants like Sodium Starch Glycolate, Crosscarmelose 
sodium, Crosspovidone by employing direct compression technique. Prepared 
tablets were evaluated for angle of repose, weight variation, Hardness, % friability, 
wetting time, drug content, disintegration and invitro dissolution studies.The results 
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of stability studies revealed no change in physical appearance, drug content and 
in-vitro dissolution profile, thus indicating that formulations was stable. FTIR 
studies revealed that there was no significant interaction between drug and 
polymer in the formulations. Among all the formulations (F1-F18), F-15 was found 
to be optimized as compared to other formulations. 
   
Kameswara Rao S et al., (2015), formulated Enalapril maleate oral 
disintegrating tablet by using natural and synthetic super disintegrents. ODTs may 
also be used to deliver drugs to the oral cavity, for local action or, in some cases, 
absorption across the oral mucosa, thereby avoiding first-pass hepatic metabolism 
and potentially increasing the rate and extent of uptake, and reducing undesirable 
metabolites. The objectives of the research work is to formulate oral disintegrating 
tablets of Enalapril maleate by using different super disintegrates (Natural, 
Synthetic) in different ratio by direct compression technique and tablets were 
evaluated for pre compressional and post compressional Parameters such as 
angle of repose, bulk density, tapped density, compressibility index, drug content 
and in-vitro drug release study, hardness, friability, wetting time and in vitro 
dispersion time. To study the physical characteristics of the individual drug and 
optimized formulations by FTIR spectroscopy. To evaluate various characteristics 
of the resulting tablets. Formulation CCS3, IH2 were subjected to stability Studies 
as per ICH guidelines at temperatures and humidity of 25±5ºC/60±5%RH; and 
40±5ºC/75±5%RH. Tablets didn’t reveal any appreciable changes in respect to 
hardness, disintegration time, drug content and dissolution profile. 
 
Hemalatha K P et al., (2015), developed and evaluated orodispersible 
tablets of lafutidine. Tablets were prepared by direct compression by using three 
superdisintegrants of sodium starch glycolate ,crospovidone and Croscarmellose 
Sodium were used alone as well as in combination. The combination of 
superdisintegrants gave better disintegration effect. Micro crystalline cellulose was 
used as diluent, mannitol and aspartame were used to enhance the organoleptic 
properties of tablets. The dissolution studies were conducted in 900 ml of pH 6.8 
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phosphate buffer. The optimized formulation F-12 showed good release profile 
with maximum drug release at all time intervals. The drugs with other excipients 
were interaction evaluated by FTIR. FTIR spectrum of pure drug was compared 
with other formulations. All peaks corresponding to the different functional groups 
of the pure drug were present in the formulations which indicate the absence of 
interaction between the drug and excipients. The selected formulation F-12 was 
subjected for stability studies as per ICH guidelines. Formulations subjected for 
stability studies were checked for drug content, hardness, friability and physical 
appearance for 90 days with an interval of 15 days. The formulations were found 
to be stable as no significant change was observed in the various evaluated 
parameters of the formulations. It was concluded that orodispersible tablets of 
Lafutidine could be prepared by using blend of all three superdisintegrants. The 
present study demonstrated potentials for rapid absorption, improved 
bioavailability, effective therapy and patient compliance. 
 
 
Gugulothu D et al., (2015), developed sumatriptan succinate 
orodispersible tablets by freeze drying technology. The tablet excipients were 
screened and the composition was optimized based on parameters which 
involved general appearance, tablet size and shape, uniformity of weight, 
mechanical properties, surface pH, moisture analysis, drug content, wetting 
time, in vitro and in vivo disintegration time. Furthermore, Fourier transform 
infrared spectroscopy, differential scanning calorimetry, scanning electron 
micrograph of cross- section of the tablet and in vitro dissolution studies were 
performed. Studies revealed that formulation containing gelatin-mannitol (3.75% 
w/v and 3.5% w/v, respectively) with camphor as a volatile pore forming agent 
exhibited superior properties with disintegration time of less than 10 s. 
Furthermore, in vitro release studies revealed 90% release of drug from 
developed dosage form within 10 min, thus suggesting rapid drug dissolution 
followed by faster onset of action, which formed a strong rationale for 
development of ODTs of sumatriptan succinate. 
CHAPTER                                                          II LITERATURE REVIEW 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 44 
 
 
Subramanian S et al., (2014), prepared Cetirizine orodispersible tablets 
to achieve quick onset of action and for maximum bioavailability. Tablets were 
prepared using cetirizine along with camphor and mannitol in the proportion of 
1:1:1, 1:1:3, and 1:1:6. The flow property of granules was found to be good for 
the formulation CZ2 (1:1:3). The hardness and friability of all the formulations 
were found to be within the standard limit for orodispersible tablets. 
Disintegration time was found to be rapid in formulation CZ2 (1:1:3).The in vitro 
dissolution time was found to be 100% in 11 minutes for the formulation CZ2 
(1:1:3). 
 
Dr Saleem M A et al., (2014), formulated and evaluated the oral dissolving 
films of levocetrizine. Levocetirizine is a selective, long acting peripheral 
H1receptor antagonist. Allergic rhinitis is a symptomatic disorder of the nose 
induced by inflammation mediated by immunoglobulin E (IgE) in the membrane 
lining the nose after allergen exposure. Thus, formulating Levocetirizine into a fast 
dissolving dosage form would provide fast relief. Levocetirizine is bitter in taste so 
ß-cyclodextrin was used to mask the taste. Inclusion complexes of drug ß-
cyclodextrin were prepared by kneading method in 1:1 molar ratios. The prepared 
inclusion complexes were characterized by FTIR spectroscopy suggesting no 
interaction. The oral fast dissolving films were prepared by using different 
polymers like HPMC, PVA, PVP and carbopol 934P with super disintegrants like 
sodium starch glycolate and croscarmellose sodium. The prepared films evaluated 
for folding endurance, swelling index, surface pH, in vitro disintegration time, drug 
content, FTIR Study, Scanning electron microscopy and in vitro drug release. The 
physical appearance and folding endurance properties were found to be good and 
electron microscopy shows that films are clear, colourless with smooth surface 
without any scratches. The average folding endurance time found within the range 
of 121 to 198 times. The drug content found to be 93.33% to 98.68% shows 
uniform mixing of drug in all prepared fast dissolving films. The in vitro 
disintegration time found to be in the range of 15 to 48sec and the surface pH of 
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the all formulations was in the range of 6.06 to 6.83. The in vitro drug release 
showed 77.77 to 96.80 % drug release within 10 minutes. The formulations F7 to 
F12 showed highest drug release which contains croscarmellose as 
superdisintegrant, among these formulations F7, F8 and F11 showed highest drug 
release. 
 
Jahufar Sathik et al., (2014),  prepared bilayer tablet of Montelukast 
sodium and Levocetrizine HCL for the treatment of asthma and allergic rhinitis. 
Bilayer tablet of Montelukast Sodium and Levocetrizine HCL was successfully 
developed. Immediate release of Montelukast was formulated with 
crosscaramellose sodium and Levocetrizine layer with starch granules as 
disintegration. IR spectrum revealed that there is no disturbance in the principle 
peaks of pure drugs of Montelukast sodium and Levocetrizine HCL. This indicates 
there was no interaction between the drug and excipient.The formulation showed 
good flow property and compressibility index. The angle of repose was ranged 
from 25.0˚±1.40 to 31.4˚±0.97 for Montelukast sodium and 25.2˚±1.40 to 29.5˚± 
0.68 for Levocetrizine HCL. The compressibility index was found range from 11.6 
to 22.2 for Montelukast sodium and 14.1 to 27.8 Levocetrizine HCL. Hausner’s 
ratio was found to be 1.143 to 1.287 for Montelukast sodium and 14.1 to 27.8 for 
Levocetrizine HCL. The result of the angle of repose indicates good flow property 
of the granules and the values of compressibility index further showed support for 
the flow property. The prepared tablets were evaluated for hardness, friability, 
weight variation, drug content uniformity. The results were found within the limits. 
Among the various formulations prepared, Formulation F8 with croscarmellose 
sodium (20%) shows minimum disintegration time and improved dissolution 
properties compared to formulation F-1 to F-7. This is because of the dual action 
of wicking and swelling property of disintegrants. The stability studies were carried 
out for the optimized formula for three months and it show acceptable results. 
Hence, Montelukast sodium and Levocetrizine HCL bilayer tablets can be used for 
alternative dosage form in the effective treatment of patients suffering from allergic 
rhinitis and bronchial asthma. 
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Reddy et al. (2013) prepared quetiapine fumarate taste masked fast 
dissolving tablets by sublimation technique. Superdisintegrant selected was 
crospovidone with camphor, menthol, and urea as sublimating agent. The 
formulated tablets were tested for various post compression parameters like 
variation in weight, hardness, friability, content uniformity, disintegration time, 
wetting time, water absorption ratio, and dissolution testing. The powder blend 
used for formulation was evaluated for the pre-compression parameters. The 
pre-compression parameters used for bulk characterization were found within 
prescribed limits and indicated good powder flow characteristics. The results 
obtained indicated that the amount of crospovidone and camphor significantly 
affect rate of drug release and disintegration time. The results concluded that 
fast dissolving tablets of quetiapine fumarate exhibit enhanced dissolution rate, 
which lead to better drug bioavailability effectiveness and hence patient 
compliance. 
 
Shobhit S et al., (2013), formulated Mouth Dissolving Tablets (MDTs) of 
Aceclofenac by direct compression technique. Sodium starch glycolate and 
crospovidone were employed as superdisintegrants in various concentrations 
like 2%, 3% and 4% w/w. All prepared tablets were evaluated for weight 
variation, hardness, drug content, friability, disintegration time, in vitro wetting 
time and percent drug release. MDTs containing 4% w/w concentration of 
crospovidone gave best results and is therefore considered as the best formula. 
It had shown 30 s disintegration time, 25 s wetting time and 79.34% in vitro 
release of drug in 25 min. 
 
Mote et al. (2013), formulated dispersible tablets of cefpodoxime proxetil by 
direct compression technique. The composition of dispersible tablet of 
cefpodoxime proxetil was crosscarmellose sodium, sodium starch glycolate, 
crospovidone XL10. From the above study it was concluded that process 
parameter like hardness, thickness and friability has significantly affect on 
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performance of the dispersible tablet. As the concentration of superdisintegrant 
increases the drug release also increased significantly. It was observed that the 
dispersible tablets of cefpodoxime proxetil with crospovidone showed better drug 
release and disintegration time in comparison to other formulations consisting of 
croscarmellose sodium & sodium starch glycolate. 
 
Patni Sonal D et al.,(2013), formulated fast dissolving tablets of 
Salbutamol sulphate by direct compression method for better patient compliance 
and immediate action in asthma. The tablets were prepared by using synthetic 
superdisintegrants (Croscarmellose sodium and Sodium starch glycolate) and 
natural superdisintegrant (mucilage of Plantago ovata and Plantago ovata husk 
powder) at different concentrations as 2, 4, 6, 8 and 10 %. The Plantago ovata 
mucilage was extracted from the seeds of Plantago ovata (Plantaginaceae).The 
tablets were characterized for weight variation, hardness, friability, disintegration 
time, wetting time, water absorption ratio, drug content and in vitro dissolution 
tests. The Drug excipients compatibility study was performed by DSC and IR 
spectroscopy and no incompatibility was found. The tablets were subjected for 
accelerated stability study at 40°C /75% RH and were found to be stable. The 
results clearly shows Natural superdisintegrants requires less disintegration time 
as compared to synthetic superdisintegrants. Hence present study reveals that the 
fast dissolving tablets prepared by using mucilage of Plantago ovata and husk 
powder of Plantago ovata as superdisintegrants having better appearance and 
rapid disintegration time. 
 
Patel A K et al., (2012), prepared fast dissolving tablets containing 
Carbamazepine as a model drug using natural and synthetic superdisintegrants 
such as isolated mucilage of Plantago ovata and croscarmellose sodium and 
sodium starch glycolate respectively by direct compression method. Prepared 
formulations were evaluated for precompression parameters such as micromeritic 
properties like angle of repose, %compressibility and Hausner’s ratio. Tablets 
were also subjected to postcompression analysis for the parameters such as 
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weight variation, hardness, friability, in vitro disintegration time, wetting time, drug 
content, in vitro dissolution study, and stability studies. The prepared tablets were 
characterized by FTIR for drug-excipient compatibility study. No chemical 
interaction between drug and excipients was confirmed by FTIR studies. The 
stability study conducted as per the ICH guidelines and the formulations were 
found to be stable. The results concluded that amongst all formulations prepared 
with mucilage of Plantago ovata showed better superdisintegrating property than 
the most widely used synthetic superdisintegrant like croscarmellose sodium and 
sodium starch glycolate. 
Vikas Sharma et al., (2012), formulated fast dissolving tablets of Carvedilol   
using various natural superdisintegrant like Plantago ovata, Lepidium sativum, 
Fenugreek and Guar gum. A Direct compression method was used to prepare fast 
dissolving tablets containing Carvedilol as a model drug using natural 
superdisintegrants. Prepared formulations were evaluated for Precompression 
parameters such as micromeritic properties like angle of repose, %compressibility 
and Hausner’s ratio. Tablets were also subjected to Postcompression analysis for 
the parameters such as weight variation, hardness, and friability, in vitro 
disintegration time, wetting time, drug content and in vitro dissolution study. The 
results concluded that amongst all formulations, the formulation prepared with 
mucilage of Plantago ovata showed better disintegrating property as well as the 
release profile than the other used natural superdisintegrant. 
Himansu Chopra et al., (2012), developed mouth dissolving tablet of 
levpceirizine hydrochloride that disintegrates rapidly in mouth by using tasteless 
complex of Levocetirizine and Tulsion-335. Effect of different parameters such as 
swelling time, resin activation, drug resin ratio as well as stirring time was 
optimized by taste and percentage drug loading. Formulated DRC (Drug Resin 
Complex) was characterized by infrared spectroscopy, thermal analysis and X-ray 
diffraction pattern. Tablets were formulated by wet granulation with PVP as binder, 
Sodium Starch Glycolate (SSG) and Crospovidone as super disintegrants. In 
these batches optimum hardness was achieved but disintegration time was found 
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to be very high as ≥ 70 second, so further trials were planned by using different 
superdisintegrants such as Croscarmellose sodium, Sodium Starch Glycolate 
(SSG) as well as Crospovidone by wet granulation method. Tablets formulated 
with 7.5% crospovidone showed comparatively low disintegration time (25 sec), 
wetting time (20 sec) and friability (0.60 %) than the other batches. In present 
study we optimized the conditions required for maximum drug loading of 
Levocetirizine with Tulsion-335. Among different superdisintergants, crospovidone 
was found suitable with drug-resin complex to get the low disintegration time, 
wetting time and friability of tablets. 
 
Rajshree Panigrahi et al., (2012), formulated the fast dissolving tablets of 
Lisinopril using natural superdisintegrants in combinations. Various formulations 
were prepared by direct compression using different combinations of natural 
superdisintegrant i.e. isolated mucilage of Plantago ovata, isolated mucilage of 
Aloe vera and extracted mucilage of Hibiscus rosasinesis to achieve optimum 
release profile, disintegration time and hardness. Microcrystalline cellulose was 
used as diluent and mannitol as bulking agent. The initial compatibility studies 
between the drug and excipients were carried out using FTIR spectroscopy. The 
tablets were evaluated for weight variation, hardness, friability, in-vitro 
disintegration time and drug release characteristics. Hardness indicated good 
mechanical strength around 2-3 kg/cm2 for all the batches. The results of in-vitro 
disintegration time indicated that the tablets dispersed rapidly in mouth within 40 
secs. It was concluded that superdisintegrants addition technique is a useful 
method for preparing orally disintegrating tablets by direct compression method. 
  
Sharma V et al., (2012), developed mouth dissolving tablet that 
disintegrated rapidly in mouth by using tasteless complex of Levocetirizine and 
Tulsion-335. Effect of different parameters such as swelling time, resin 
activation, drug resin ratio as well as stirring time was optimized by taste and 
percentage drug loading. Formulated DRC (Drug Resin Complex) was 
characterized by infrared spectroscopy, thermal analysis and X-ray diffraction 
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pattern. Tablets were formulated by wet granulation with PVP as binder, 
Sodium Starch Glycolate (SSG) and Crospovidone as super disintegrants. In 
those batches optimum hardness was achieved but disintegration time was 
found to be very high as ≥ 70 second, so further trials were planned by using 
different superdisintegrants such as Croscarmellose sodium, Sodium Starch 
Glycolate (SSG) as well as Crospovidone by wet granulation method. Tablets 
formulated with 7.5% crospovidone showed comparatively low disintegration 
time (25 sec), wetting time (20 sec) and friability (0.60 %) than the other 
batches. Among different superdisintegrants, crospovidone was found suitable 
with drug-resin complex to get the low disintegration time, wetting time and 
friability of tablets. 
 
Lakshmi P K et al., (2011), prepared the orodispersible tablets of 
ondansetron hydrochloride with synthetic and natural superdisintegrants. Various 
formulations were prepared by direct compression using different concentrations 
of natural superdisintegrant i.e. isolated mucilage of Plantago ovata and synthetic 
superdisintegrants namely Kyron T-314, crospovidone, and croscarmellose 
sodium ranging from 0.4% to 2%. The initial compatibility studies between the drug 
and excipients were carried out using FTIR spectroscopy. The blend was 
evaluated for additive properties. The tablets were evaluated for physical 
parameters and in vitro drug release. The disintegration time and in vitro drug 
release of optimized formulation (FK5) was compared with that of marketed 
formulation. The disintegration time was found to be 32 sec as compared to 49 sec 
for marketed formulation. The dissimilarity (f1) and similarity factors (f2) were 
calculated for optimized and marketed formulation and values were found to be 
9.63 and 52.46, respectively. The optimized formulation was subjected to stability 
studies for three months. The formulation was found to be stable, with insignificant 
change in the hardness, disintegration time, drug content and in vitro drug release 
pattern. 
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Gopal Satishkumar Gandhi et al.,(2011),  prepared orodispersible tablet 
of levocetirizine as  antihistaminic agent was prepared by direct compression 
method using crosspovidone, Crosscarmellose and Indion 414, as 
superdisintegrants. FT-IR study shows that there is no significant interactions 
occur between drug and excipient. The tablets prepared were evaluated for 
various parameters like various density parameters, thickness, hardness, friability, 
disintegration time, wetting time and In-vitro dissolution time. All the parameters 
were found to be within limits. The developed formulation of levocetirizine batch F8 
(10% Indion 414) showed good palatability and dispersed within 30 seconds as 
compare to crosscarmellose sodium and crosspovidone. When the results were 
compared with that of convectional tablets was found to be better with respect to 
simple manufacturing and allergic rhinitis. 
 
Prameela Rani et al.,(2010),  prepared fast disintegrating tablets of 
Metformin hydrochloride in the oral cavity with enhanced dissolution rate. The 
tablets were prepared with Isphagula husk, natural superdisintegrant and 
Crosspovidone, synthetic superdisintegrant. The pure drug and formulation blend 
was examined for angle of repose, bulk density, tapped density, Compressibility 
index and Haussner’s ratio. The prepared tablets were evaluated for hardness, 
tensile strength, drug content, friability and were found satisfactory. The 
disintegration time in the oral cavity was also tested and was found to be around 
10sec. Based on dissolution rate the disintegrants can be rated as Isphagula husk 
> Crosspovidone. Hence Ishagula husk was recommended as suitable 
disintegrant for the preparation of direct compression melt‐in‐mouth tablets of 
Metformin hydrochloride. All the dissolution parameters were calculated and 
compared with market tablet. A 3.78 fold increase in the dissolution rate was 
observed with F4 sformulation when compared to market tablet(Glucophage). It 
was concluded that the rapidly disintegrating tablets with proper hardness, rapid 
disintegration in the oral cavity with enhanced dissolution rate can be made using 
super disintegrants (natural and synthetic). 
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Nikku D Yadav et al.,(2010),  prepared fast dissolving tablets of Aspirin  
used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce 
fever, and as an anti-inflammatory medication. In the present study, the effects of 
a natural superdisintegrants and synthetic superdisintegrants were compared in 
the formulations of fast dissolving tablets (FDT). FDTs of Aspirin were prepared by 
direct compression method. These tablets were evaluated for weight variation, 
hardness, thickness, disintegration time, dispersion time, friability, wetting time, 
water absorption ration and dissolution. Swelling index was also observed with an 
objective to compare the swelling property of Plantag ovata husk with Ac-di-sol, 
Crospovidone and sodium Starch glycolate. Plantago ovata husk showed the 
highest swelling index. Hence, it is concluded that natural superdisintegrants (husk 
of Plantago ovata ) showed better disintegrating property than the most widely 
used synthetic superdisintegrants like Crospovidone, Ac-di-sol and Sodium starch 
glycolate in the formulations of FDTs. 
  
 Santanu Chakraborty et al., (2008),  studied about  the effects of a natural 
superdisintegrant vis-à-vis isolated mucilage of Plantago ovata and synthetic 
superdisintegrants like sodium starch glycolate (SSG) and croscarmellose sodium 
(Ac-di-sol) were compared in the formulations of fast dissolving tablets (FDT). 
FDTs of aceclofenac (model drug) were prepared by direct compression method 
using microcrystalline cellulose as direct compressible vehicle. Those tablets were 
evaluated for weight variation, hardness, disintegration time, drug content, friability 
and dissolution. Swelling index was also investigated with an aim to compare the 
swelling property of mucilage of Plantago ovata with SSG and Ac-di-sol. Among all 
the super disintegrants, Plantago ovata mucilage showed the highest swelling 
index. Hence, the present study revealed that this natural superdisintegrant 
(Plantago ovata mucilage) showed better disintegrating property than the most 
widely used synthetic super disintegrants like SSG and Ac-di-sol in the 
formulations of FDTs. 
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AIM OF WORK 
 Difficulty in swallowing (dysphagia) is a common problem of all age groups, 
especially the geriatric and pediatrics, because of physiological changes 
associated with those groups. Other categories that experience problems in using 
conventional oral dosage forms include the mentally ill, uncooperative and patients 
suffering from nausea, motion sickness (kinetosis), sudden episodes of allergic 
attack or coughing. Sometimes it may be difficult to swallow conventional products 
due to non-availability of water. These problems led to the development of a novel 
type of solid oral dosage form called orodispersible tablet, which 
disintegrates/dissolves rapidly in saliva without the need of drinking water. The 
faster the drug into solution, quicker the absorption and on set of action.   
 The basic approach in the development of the ODTs is the use of  
superdisintegrants. Many approaches have been developed to manufacture 
ODTs. These include direct compression, lyophilization and molding. The direct 
compression method is inexpensive and convenient for producing tablets of 
sufficient mechanical strength. 
 Many potent drugs have low dose in such cases diluents provide the 
required bulk of the tablet when the drug dosage itself is inadequate to produce 
tablets of adequate weight and size. Usually the range of diluents may vary 
from 5- 80%. Diluents also synonymously known as fillers are often added to 
tablet formulations for secondary reasons like to provide better tablet properties 
such as, to provide improved cohesion, to allow direct compression 
manufacturing, to enhance flow and to adjust weight of tablet as per die 
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capacity.  
Antihistamines are the drug of choice for Allergic Rhinitis, chronic idiopathic 
urticaria and seasonal year round allergies and relieve from itching caused by 
hives (patches of red, swollen, itchy skin). Levocetirizine hydrochloride is a third 
generation non-sedative antihistamine developed from the second generation 
antihistamine cetirizine. It works by blocking histamine receptors. It does not 
prevent the actual release of histamine from the mast cells, but prevents it binding 
to its receptors. This in turn prevents the release of other allergy chemicals and 
increased blood supply to the area and provides relief from the typical symptoms 
of hay fever. 
In the present study, orodispersible tablets of levocetirizine hydrochloride, 
are designed by using synthetic superdisintegrants (crospovidone and 
croscarmellose sodium) and natural superdisintegrants (hibiscus leaves mucilage 
and planago ovata seed mucilage). The designed tablets were evaluated for 
thickness, hardness, friability, weight variation, in vitro dispersion time, wetting 
time, water absorption ratio, disintegration time, drug content uniformity, in vitro 
dissolution rate (in pH 6.8 phosphate buffer), short term stability and drug excipient 
interactions (IR spectroscopy). 
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PLAN OF WORK 
I. PREPARATION OF STANDARD CALIBRATION CURVE: 
 A. Determination of  λmax for Levocetrizine hydrochloride  
 B. Calibration of Levocetrizine hydrochloride 
 
II. COMPATIBILITY STUDIES FOR DRUG AND EXCIPIENTS: 
A. Fourier transform Infra-Red Spectroscopic (FTIR) studies 
B. Differential scanning calorimetry(DSC) studies 
 
III. PREFORMULATION EVALUATION OF POWDER BLEND: 
A. Angle of repose (θ) 
B. Bulk density 
C. Tapped density 
D. Carr’s index (I) or % compressibility 
E. Hausner’s ratio 
 
IV. FORMULATION OF LEVOCETRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS: 
A. Using  different super disintegrants 
B. By direct compression 
 
V. EVALUATION OF POST COMPRESSION PARAMETERS  OF 
ORODISPERSIBLE TABLETS: 
A. General appearance 
B. Tablet thickness and diameter  
C. Hardness 
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D. Weight variation test  
E. Friability test 
F. Uniformity  of Drug content 
G. Invitro drug  release study 
H. Invitro disintegration time  
 I. Water absorption ratio 
 J. Wetting time 
 
VI.  EFFECT OF SYNTHETIC SUPERDISINTEGRANTS ON RELEASE 
PROFILE OF LEVOCETRIZINE HYDROCHLORIDE ORODISPERSIBLE 
TABLETS 
 
VII. EFFECT OF NATURAL SUPERDISINTEGRANTS ON RELEASE PROFILE 
OF LEVOCETRIZINE HYDROCHLORIDE ORODISPERSIBLE TABLETS 
 
VII. COMPARISION OF DISSOLUTION DATA OF LEVOCETRIZINE 
HYDROCHLORIDE TABLETS CONTAINING DIFFERENT 
SUPERDISINTEGRANTS 
 
IX. SELECTION OF BEST FORMULATION 
 
X. EVALUATION OF SELECTED FORMULATION 
A.  Differential scanning calorimetry(DSC) study for best formulation. 
B.  Fourier transform Infra-Red Spectroscopic (FTIR) study for best formulation. 
 
XI.DRUG RELEASE KINETIC  MODEL FOR THE BEST STUDIES 
XII.STABILITY STUDIES 
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MATERIALS AND EQUIPMENTS 
 
MATERIALS 
 
DISTRIBUTORS 
Levocetirizine Hydrochloride Madras Pharma,Chennai. 
Microcrystalline cellulose Madras Pharma , Chennai. 
Sodium starch glycolate Madras Pharma , Chennai. 
Crospovidone .Madras Pharma , Chennai. 
Plantago ovata seed Local market, Madurai. 
Hibiscus leaves mucilage Self made 
Mannitol Madras Pharma , Chennai. 
Magnisum stearate Madras Pharma,Chennai. 
Talc Madras Pharma,Chennai. 
Saccharin sodium Madras Pharma,Chennai. 
Aerosil Madras Pharma,Chennai. 
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EQUIPMENT AND SUPPLIERS 
 
EQUIPMENTS SUPPLIERS 
Electronic Weighing Balance A & D Company,Japan. 
Multi punch tablet compression 
machine 
B/D tolling compression machine 
UV Visible spectrophotometer Shimazdu UV-1700,Japan 
Digital tablet dissolution apparatus Lab India Disso Apparatus 2000, 
India 
Friabilty test apparatus Indian Equipment Corporation, 
Mumbai 
Tablet Hardness Tester Scientific Engineering Corporation 
Digital Vernier Caliper Linker, Mumbai 
Disintegration Test Apparatus Rolex, India 
Fourier Transform Infra Red 
Spectroscopy 
Shimadzu, Japan 
Hot Air Oven Industrial Headans, Chennai 
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DRUG PROFILE 
LEVOCETIRIZINE HYDROCHLORIDE 
CHEMICAL NAME 
(R)-2-[2-[4-[4-chloro-phenyl) phenyl methyl] piperazin-1-yl] ethoxy] acetic acid 
hydrochloride. 
STRUCTURE 
 
 
MOLECULAR FORMULA 
C21H26Cl2N2O3 
MOLECULAR WEIGHT 
425.35 g/mol 
DESCRIPTION 
Appearance          : A white or almost white powder 
Melting point         : 130 to 174°C 
Boiling point          : 346 to 542°C 
Density                : 1.24gm/cm3 
Refractive index : 1.59 
Solubility              : Soluble in water 
Storage condition  : Protect from moisture 
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MECHANISM OF ACTION 
Histamine meaning ‘tissue amine’ (histos-tissus) is almost ubiquitously 
present in animal tissues and in certain plants. It was implicated as a mediator 
of hypersensitivity phenomena and tissue injury reactions. Histamine is present 
mostly within storage granules of mast cells. Tissues rich in histamine are skin, 
gastric acid and intestinal mucosa, lungs, liver and placenta. Histamine is also 
present in blood, most body secretions, venoms and pathological fluids. 
SYNTHESIS, STORAGE AND DESTRUCTION 
It is synthesized locally from the amino acid histidine and degraded 
rapidly by oxidation and methylation. In mast cells, histamine (positively 
charged) is held by an acidic protein and heparin (negatively charged) within 
intracellular granules. Granules are extruded by exocytosis. Increase in 
intracellular CAMP (Caused by β adrenergic agonists and methylxanthines) 
inhibits histamine release.  
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PHARMACOLOGICAL EFFECT 
 
 
 
SECOND GENERATION ANTI-HISTAMINES 
Properties 
 
 Absence of CNS depressant property 
 Higher H1 selectivity, no anti-cholinergic side effects. 
 Additional anti-allergic mechanisms apart from histamine blockade, 
some also inhibit late phase allergic reaction by acting on leukotrienes or 
by antiplatelet activating factor effect. 
 Minimally or nonsedating because oftheir limited penetration of the 
blood-brain barrier. 
CLASSIFICATION 
 Fexofenadine 
 Loratidine 
 Desloratidine 
 Cetirizine 
 Levocetrizine 
 Azelastine 
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 Mizolastine 
 Ebastine 
 Rupatadine 
 
Levocetirizine hydrochloride is a second generation antihistamine, 
developed from the cetirizine. Levocetirizine works by blocking histamine 
receptors. It does not prevent the actual release of histamine from mast cells, 
but prevents it binding to its receptors. This in turn prevents the release of other 
allergy chemicals and increased blood supply to the area, and provides relief 
from the typical symptoms of hay fever.  
 
 
 
Second generation anti-histamines are specific for H1 receptor selectivity.  
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PHARMACODYNAMICS 
Levocetirizineis the active R-enantiomer of the racemate cetirizine. It is 
highly selective for the human histamine H1-receptor, at which it has twice the 
binding affinity of cetirizine. Levocetirizinecoming under the second generation 
anti-histamines. It works by blocking the release of a chemical called 
histaminethat our body makes during an allergic reaction. Levocetirizine was 
the most potent and consistently effective drug for inhibiting the 
histamine-induced wheal-and-flare surface areas.This helps relieve 
symptoms of allergies, such as sneezing, runny nose, and red, watery, itchy 
eyes. This drug also helps relieve itching caused by hives. 
ADVERSE DRUG REACTIONS 
 Rash, itching/swelling (especially of the face/tongue/throat), severe 
dizziness, trouble breathing.Fatigue, somnolence, dry mouth, nasopharyngitis, 
pyrexia, cough, epistaxis. 
PRECAUTIONS 
Drowsiness, tiredness, weakness, sore throat, dry mouth, fever, cough, 
nosebleed, urinary retention, renal impairment, may impair ability to drive or 
operate machinery. 
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OTHER DRUG INTERACTIONS 
Additive sedation with alcohol and other CNS depressants. 
DOSAGE 
The recommended dose of levocetirizine hydrochloride is 5 mg [2 
teaspoons (10 ml) oral solution] once daily in the evening. Some patients may 
be adequately controlled by 2.5 mg [1 teaspoon (5 mL) oral solution] once daily 
in the evening.It can be taken without regard to food consumption. 
FOOD (BEFORE/AFTER) 
May be taken with or without food. 
LIST OF CONTRAINDICATIONS 
Levocetirizine is contraindicated in end-stage renal disease 
patients (CrCl< 10 mL/min)and patients undergoing hemodialysis.Children 6 
months to 11 years of age with impaired renal function. 
Do not breast-feed (lactation) while take this medicine (levocetirizine 
tablets). 
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EXCIPIENT PROFILE 
CROSPOVIDONE 
Synonym: 
 Cross linked povidone 
 Kollido  
 1-vinyl-2-pyrrolidone homopolymer 
 Polyplasdone  
 Polyvinylpolypyrrolidone  
Chemical name : 
 1-Ethylene-2-pyrrolidinone homopolymer 
Functional formula : 
 
Empirical formula: 
 (C6H9NO)n 
Molecular weight: 
 >1000 000 
Functional category: 
 Tablet disintegrant. 
Application in pharmaceutical formulation or technology: 
 Tablet disintergrant and dissolution agent. 
 Solubility enhancer for poorly soluble drug  
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Description: 
 Crospovidone is a white-creamy white 
 Free flowing 
 Practically tasteless 
 Hygroscopic powder 
Melting Point: 
 150OC 
Stability and Storage condition: 
 Crospovidone is hygroscopic 
 It should be stored in an airtight container in a cool, dry place. 
Incompatibilities: 
 Crospovidone is compatible with most organic and inorganic 
pharmaceutical ingredients. 
 When exposed to a high water leval . 
 Crospovidone may form molecular adduct with some materials. 
Handling Precautions: 
 Observe normal precaution appropriate to the circumstances and 
quantity of material handled. 
 Eye protection gloves and a dust mask are recommended  
 
(Hand book of Pharmaceutical Excipients by Raymond C Rowe 5th 
Edition.) 
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SODIUM STARCH GLYCOLATE 
Nonproprietary Names 
 BP: Sodium Starch Glycolate 
 PhEur: Sodium Starch Glycolate 
 USP-NF: Sodium Starch Glycolate 
 
Synonyms 
 Carboxymethyl starch, 
 sodium salt; 
 carboxymethylamylum natricum; 
 Explosol; 
 Explotab;  
 Glycolys; Primojel; 
 starch carboxymethyl ether,  
 sodium salt; Tablo; Vivastar P. 
 
Chemical Name  
 Sodium carboxymethyl starch  
 
Empirical Formula  
 C2H4O3 x Na x-Unspecified 
 
Fragment 
 C2H4O3 Component  Na Unspecified 
 
Molecular weight 
 Sodium starch glycolate may be characterized by the degree of 
substitution and crosslinking. The molecular weight is typically 5 x105 – 1 
x 106. 
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Structural Formula 
 
 
 
Functional Category 
 Tablet and capsule disintegrant. 
 
Applications in Pharmaceutical Formulation or Technology 
 Sodium starch glycolate is widely used in oral pharmaceuticals as a 
disintegrant in capsule and tablet formulations.  
 It is commonly used in tablets prepared by either direct-compression or 
wet-granulation processes.  
 The usual concentration employed in a formulation is between 2% and 
8%, with the optimum concentration about 4%, although in many cases 
2% is sufficient..  
 Increasing the tablet compression pressure also appears to have no 
effect on disintegration time.  
 Sodium starch glycolate has also been investigated for use as a 
suspending vehicle. 
 
Description 
 Sodium starch glycolate is a white or almost white free-flowing very 
hygroscopic. 
 
Melting point  
 Does not melt, but chars at approximately 2000C 
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Solubility 
 Practically insoluble in methylene chloride. It gives a translucent 
suspension in water.powder. 
 
Stability and Storage Conditions 
 Tablets prepared with sodium starch glycolate have good storage 
properties.  
 Sodium starch glycolate is stable although very hygroscopic, and should 
be stored in a well-closed container in order to protect it from wide 
variations of humidity and temperature, which may cause caking.  
 The physical properties of sodium starch glycolate remain unchanged for 
up to 3 years if it is stored at moderate temperatures and humidity. 
 
Incompatibilities 
 Sodium starch glycolate is incompatible with ascorbic acid. 
 
Safety  
 Sodium starch glycolate is widely used in oral pharmaceutical 
formulations and is generally regarded as a nontoxic and nonirritant 
material. However, oral ingestion of large quantities may be harmful  
 
Handling Precautions 
 Observe normal precautions appropriate to the circumstances and 
quantity of material handled.  
 Sodium starch glycolate may be irritant to the eyes; eye protection and 
gloves are recommended.  
 A dust mask or respirator is recommended for processes that generate a 
large quantity of dust. 
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HIBISCUS LEAVES 
 
Genus name      :   Hibiscus. 
Synonyms                  :  Hibiscus elatus, bladder ketmia, Jamaica sorrel,    
Confederate rose mallow, red sorrel, swamp rose 
mallow                
Family    :   Malvaceae 
Description          : The leaves ate 3.5-12 cm. In length and 2-5.5 cm wide.      
Leaves are simple ovate or ovate-lanceolate. Leaves are entire at the base and 
coarsely toothed at the apex. 
 
Description Hibiscus leaves- β-sitosterol, stigma 
sterol, taraxeryl acetate and three 
cyclo propane compounds and their 
derivatives. 
Bulk density 0.142 gm/ml 
Tapped density 0.2 gm/ml 
Total ash value of crude drug 14 % (w/w) 
Acid insoluble ash 5.5 % (w/w) 
Water soluble ash 0.5 % (w/w) 
Sulphated ash 9 % (w/w) 
Loss on drying   86 % (w/w) 
Swelling index 
1 gm drug make up to 20ml with water 
4.5 ml 
Foaming index 5 ml conc- 0.5 ml 
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Properties: 
 It is mainly used in the anti-diabetic activity and cosmetics. 
 Treating tuberculosis and lung disease. The first benefits is being able to 
help treat tuberculosis.  
 It is used for treating the disease cough. 
 It is used for treating the tonsils to swell.  
 Treatment for curing colitis.  
 Treatment for vomiting blood.  
 Can stop bleeding.  
 Treatment for hair loss. 
 
Application in pharmaceutical formulation: 
  Hibiscus-Rosa Sinesis leaf mucilage exhibit excellent retarding effect on 
drug release from the floating tablets. 
 Hibiscus-Rosa Sinesis leaf mucilage swells well when contact with water 
in the colon and release the drug in sustained and controlled manner for 
long time 
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PLANTAGO OVATA SEED 
 
Genus name   : Plantago. 
Synonyms      : Psyllium seed; Plantain seed; Isabgol; Ishabgul Spogel seed. 
Family           : Plantaginaceae. 
Description    : White, pale buff or off white colour. 
 
Composition:   
Description Phylum husk is purely dietary fibrt, 
composed mostly of hemicelluloses 
Mucilloid content 95% 
Fibre content 47% soluble fiber 
sugars Arabinose and xylose sugars 24% and 
53% respectively. 
Moisture-Maxi 10% 
Swell volume 40 ml/g 
Total Ash- Maxi 4% 
Acid insoluble Ash 1% Max 
  
Properties: 
 It is a natural product without any chemicals. 
 It is non-toxic 
 It has high affinity to water. It swells after absorption of water. 
 It is emollient, demulcent and laxative. 
 It is bland in taste. 
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Application in pharmaceutical formulation: 
 Isphagula husk is widely used in oral   pharmaceuticals as a disintegrant 
in tablets formulation. 
 It swells when it come in contact with liquids. 
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MANNITOL 
 
Synonym: 
 Cordycepic acid 
 Manna sugar 
 D- mannite 
 Mannogem 
 Pearlitol 
 
Chemical Name: 
 D-Mannitol 
 
Empirical Formula: 
 C6H14O6 
 
Molecular Weight: 
 182.17 
 
Structural Formula: 
 
 
Functional Category: 
 Diluents 
 Sweetening agent 
 Tonicity agent 
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Applications: 
 It is used as a diluent in tablet formulations. (10-90% w/v) 
 It is used in pharmaceutical formulations and food products. 
 It is used in tablet applications include antacid preparation 
glyceryltrinitrite tablets and vitamin preparations. 
 It is used as an excipient in the manufacture of chewable tablet 
formulation. 
 It is also used in sweetness and mouth feel due to its negative 
heat of solution. 
 In lyophilized preparations, mannitol (20-90%w/w) had been 
included as a carrier to produce a stiff, homogenous cake that 
improves the appearance of the lyophilized plug in vial. 
 It is used in food application as a bulking agent. 
 Mannitol administered parentally is used as an osmotic diuretic, 
it is used in diagnostic agent for kidney function, as an adjunct 
in the treatment of acute renal failure. 
Description: 
 Mannitol occurs as a white, odourless, crystalline powder or free 
flowing granule. 
 It has a sweet taste, approximately as sweet glucose and half 
as sweet as sucrose and imparts a cooling sensation in the 
mouth. 
 Mannitol was found to reduce the oral bio availability of 
cimetidine compared to sucrose. 
 Mannitol is reducing sugar, impurities have been implicated in 
the oxidative degradation of a peptide in a lyophilized formation. 
Handling precautions: 
 Mannitol is irritant to the eyes; eye protection is recommended.
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MICROCRYSTALLINE CELLULOSE 
Synonyms : 
 Avicel PH 
 Crystalline cellulose  
 Cellet 
 Emcocel  
 Hellulosum microcristalinum 
Chemical name: 
 Cellulose  
Empirical  formula: 
 (C6H10O5)n 
Molecular weight: 
 36000 gm/mol 
Functional category: 
 Adsorbent  
 Suspending agent  
 Tablet and capsule diluents 
 Tablet disintegrant 
Structural formula: 
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Application in pharmaceutical formulation or technology:  
 Microcrystalline cellulose is widely used in pharmaceuticals primarily as 
binder / diluents in oral tablets and capsule formulation. 
 Micerocrystalline cellulose is also used in cosmetics and food products. 
Description : 
 Microcrystalline cellulose is a white, odorless, tasteless, crystalline powder 
composed of polrous particles. 
Melting Point: 
 260-2700C 
Solubility : 
 Slightly soluble in 5% w/v NaOH  solution ,practically insoluble in water and 
most organic solvents.  
Solubility and storage condition:  
 Microcrystalline cellulose is stable though hygroscopic material. 
 It should be stored in a well-closed container in a cool, dry place. 
Incompatibilities: 
 Microcrystalline cellulose is incompatible with strong oxidizing agent. 
Handling Precautions: 
 Microcrystalline cellulose may be irritant to the eyes, Gloves, eye protection 
and dust mask are recommended.  
( Hand book of pharmaceutical Excipient by Raymond C Rowe.,5th Edition) 
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SACCHARIN SODIUM 
Synonym: 
 1,2-Benzisothiazolin-3-one 1,1-dioxide,sodium salt 
 Crystallose 
 E954 
 Sodium o-benzosulfimide 
 Soluble glucose 
 Soluble saccharin 
 Sucryl sodium 
Chemical Name: 
 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide,sodium salt 
Chemical Strucure: 
 
 
Empirical Formula: 
 C7H4NnaO3S 
 C7 H4 NNaO3 S. 1 2⁄ H2O (84%)  217.24 
 C7 H4 NNaO3 S. 2H2O (76%)  241.19  
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Molecular Weight:  
 205.16g/mol 
Functional Category: 
 Sweetening agent 
Description: 
 Saccharin sodium occurs as a white, odorless or faintly aromatic, 
efflorescent, crystalline powder. 
 Saccharin sodium can contain variable amount of water. 
Properties: 
 Acidity/Alkalinity                    :    pH=6.6 (10% w/v aqueous saccharin 
sodium) 
 Density (Bulk)                        :   0.8-1.1 g/cm3 (76% saccharin sodium)   
                                                              0.86 g/cm3 (84% saccharin sodium) 
 Density (Particle)                     :    1.70 g/cm3 (84% saccharin sodium) 
 Density (Tapped)                     :    0.9-1.2 g/cm3 (76% saccharin sodium)  
                         0.96 g/cm3 (84% saccharin sodium) 
Melting Point: 
 Decomposes upon heating. 
 >5720F (Decomposes)  
Solubility: 
 >(or) = 100mg/ml at 680F 
Specific Surface Area: 
 0.25m2/g 
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Stability and Storage Condition: 
 Saccharin sodium is stable under the normal range of conditions employed 
in formulations. Only when it is exposed to a high temperature (1250C) at 
low pH(pH2) for one hour  does significant decomposition occur. The  84% 
grade is the most stable of saccharin sodium since the 76% form will dry 
fyrther under ambient conditions. 
 Saccharin sodium should be stored in a well-closed container in a cool, dry 
place. 
Safety: 
 The WHO has se a temporary acceptable daily intake up to 2.5 mg/kg 
body-weight for saccharin, including its salts. In the UK, The Committee on 
Toxicity of Chemicals in Food, Consumer Products and the 
Environment(COT) has set an acceptable daily intake for saccharin and its 
salts (expressed as saccharin sodium) at up to 5mg/kg body-weigt. 
      LD50  (mouse,oral)     :    17.5g/kg 
      LD50  (rat,IP)              :    7.1g/kg 
      LD50  (rat, oral)           :    14.2g/kg 
 
Handling Precautions: 
 Observe normal precautions appropriate to the circumstances and quantity 
of material handled. Eye protection and dust mask are recommended.  
 (Handbook of Pharmaceuical Excipients by Raymond C Rowe 5th edition, 
1710-1715) 
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AEROSIL 
Synonyms: 
 Aerosil 
 Cab-O-sil 
 Colloidal silica 
 Fumed silica 
 Fumed silicon dioxide 
 Silicone dioxide colloidal 
Chemical name: 
 Silicon dioxide 
Empirical  formula: 
 SiO2 
Molecular weight: 
 60.08 
Functional category: 
  Adsorbent 
 Anticaking agent 
 Glidant and Tablet disintegrant 
 Emulsion stabilizer 
 Viscosity increasing agent 
 
Application in pharmaceutical formulation or technology: 
  It is improves the flow properties of the dry powders. 
  It is used as an adsorbent dispersing agent for liquids in powders. 
  Eliminate hard settling and minimize the clogging of spray nozzle 
 
 
CHAPTER VII                                                      EXCIPIENT PROFILE 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 82 
 
Description: 
 Colloidal silicone dioxide is a light, loose, bluish-white coloured, tasteless, 
odorless and amorphous powder. 
 
Melting Point: 
 1600oC 
 
Solubility: 
 Soluble in hot solution of alkali hydroxide. Practically insoluble in water, 
organic solvents and acids. 
 
Storage condition: 
 It should be stored in a well closed container. 
 
Incompatibilities: 
 It is incompatibility with diethylstilbestrol preparations. 
 
Handling Precautions: 
 A dust mask should be used, when handling small quantity. For large 
           quantities, a dust respirator is recommended. 
(www.chemicallab.com and Hand book of pharmaceutical Excipient by  
Raymond            C Rowe., 5th Edition) 
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TALC 
Synonym: 
  Altalc 
  Hydrous magnesium calcium silicate 
  Hydrous magnesium silicate 
Chemical name: 
  Talc 
  Purified talc 
  Talcum 
Empirical Formula: 
 Talc is purified, hydrated, magnesium silicate. 
  Mg6 ((Si2O5)4(OH) 4) 
  It may contain small variable amounts of silicate and iron. 
Molecular weight: 
 379.27 
Structural Formula: 
    
 
Functional Category : 
 Anticaking agent 
 Glidant 
 Diluent 
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 Lubricant 
Application in pharmaceutical formulation or technology: 
 Talc is widely used in solid dosage formulations. 
 Lubricant and Glidant. (1.0-10.0) 
 Diluents in tablet and capsule. (5.0-30) 
 It is widely used as a dissolution retardant in the development of controlled-
release products. 
 Talc is novel powder coating for extended release pellets and as an 
adsorbent. 
 It is used as a dusting powder. (concentration 90.0-99.0) 
 It is used to clarify liquids and is used in cosmetics and food products. 
 It is used in baby powder. 
Description: 
 Talc is very fine, white to grey-white, odourless, impalpable, unctuous, 
crystalline powder. It adheres readily to the skin and is soft to touch and 
free from grittiness. 
 
Melting Point: 
 800oC 
 
Solubility: 
 Practically insoluble in organic solvent, water and in dilute acids & alkalis. 
 
Stability and Storage condition: 
 Talc is a stable material and may be sterilized by heating at 160oC for not 
less than one hour. 
 It may also be sterilized by exposure to ethylene oxide or gamma radiation. 
 Talc should be stored in well closed container in a cool, dry place. 
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Incompatibilities: 
 Incompatible with quaternary ammonium compounds. 
 
Handling Precautions: 
 Talc is irritant if inhaled and prolonged exposure may cause 
pneumoconiosis. 
 In the UK, the occupational exposure limit for talc is long-term (8 hour 
TWA). Eye 
protection, gloves and respirator are recommended. 
( Hand book of  Pharmaceutical Excipients by Raymond C Rowe.,5th Edition) 
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MAGNESIUM STEARATE 
Synonym: 
 Magnesium octadecanoate 
 Octadecanoic acid 
 Magnesium salt 
 Stearic acid 
 Magnesium salt 
Chemical Name: 
 Octadecanoic acid magnesium salt (557-04-0) 
Empirical Formula: 
 Magnesium stearate as a compound of magnesium with a mixture of solid 
organic acids that consists of variable proportions of magnesium stearate 
and magnesium palmitate. 
 Magnesium stearate : C36H20MgO4 
 Magnesium palmitate : C32H62MgO4 
Molecular weight: 
 591.34 
Structural Formula: 
    
Functional Category: 
 Tablet and capsule lubricant. 
Application in pharmaceutical Formulation or Technology: 
 It is widely used in cosmetics, foods and pharmaceutical formulations.  
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  It is used as a lubricant in capsule and tablet manufacture at 
concentrations 0.25% and 5.0% w/w. 
Description : 
 Magnesium Stearate is a very fine, light white, precipitated or milled, 
impalpable 
powder of low density, having a faint odour of stearic acid and a 
characteristic taste. 
  The powder is greasy to touch and readily adheres to the skin 
Melting Point: 
 117-150OC 
Solubility: 
 Slightly soluble in warm benzene and warm ethanol. 
 Practically insoluble in ethanol and water. 
Stability and Storage condition: 
 Magnesium stearate is stable and should be stored in well closed container 
in a cool, dry place. 
Incompatibilities: 
 Incompatible with strong acids, alkalis and iron salts. 
 Magnesium stearate cannot be used with aspirin, some vitamin and most 
alkaloidal salts. 
Handling Precautions: 
 Eye protection and gloves are recommended. 
 Excessive inhalation of magnesium stearate dust may cause upper 
respiratory tract discomfort, coughing and choking. 
( Hand book of Pharmaceutical Excipients by Raymond C Rowe.,5thEdition). 
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EXPERIMENTAL PROTOCOL 
I. CONSTRUCTION OF LEVOCETRIZINE HYDROCHLORIDE 
CALIBRATION CURVE WITH PHOPHATE BUFFER pH 6.8 
 
Preparation of 0.2M potassium dihydrogen phosphate   
 27.218g of potassium dihydrogen phosphate was dissolved in 
distilled water and the volume was made up to 1000 using distilled water.  
 
Preparation of pH 6.8 phosphate buffer solution 
  Take 50 ml of 0.2M Potassium Dihydrogen phosphate in a 200ml 
volumetric flask and add 22.4ml of 0.2M Sodium hydroxide solution, then 
the volume was made upto 200ml using distilled water. 
Preparation of 0.2M sodium hydroxide  
 8g of sodium hydroxide was dissolved in distilled water and made up  
to 1000ml with distilled water. 
a.Determination of λ-max 
 100mg of Levocetirizine hydrochloride is taken in a 100ml volumetric 
flask and dissolved by using a small amount of phosphate buffer and made 
upto 100ml. This stock solution containing 1000µg/ml. This is further diluted 
into 10µg/ml. The resultant solution is scanned in the range of (200-400nm). 
b.Preparation of calibration curve 
From the above prepared stock solution, different concentration (2 
to 32μg/ml) solutions are prepared. The absorbance of these solutions 
are measured at λmax (231nm) by UV- spectrophotometer. A standard 
curve is plotted using concentration on X-axis and the absorbance 
obtained on Y-axis. 
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II. COMPATABILITY STUDIES FOR DRUG AND EXCIPIENTS 
Compatibility studies are carried out to confirm whether there are no 
interactions existing between the drug and excipients. It gives 
information needed for selection of excipients with the drug for the 
formulation. Infrared spectroscopy and Differential scanning calorimetry 
studies are the two techniques used to check the compatibility between 
drug and polymers. 
 
Fourier Transform Infra-Red spectroscopic(FTIR) studies 
FT–IR spectra were recorded for levocetirizine hydrochloride pure 
drug and pure drug with excipients using IR- spectrophotometer. The 
samples were prepared in KBr dish and scanned over 4000 to 400 cm-1. 
 
III. PRECOMPRESSION EVALUATION OF POWDER BLEND 
The goals of the preformulation study are  
 To establish the necessary physicochemical characteristics of a 
new drug substance. 
 To determine its kinetics release rate profile. 
 To establish its compatibility with different excipients.  
 
a. Angle of Repose: 
The friction forces in a loose powder can be measured by the angle 
of repose (θ). It is an indicative of the flow properties of the powder. It is 
defined as the maximum angle possible between the surface of the pile of 
powder and the horizontal plane 
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Where, 
 θ   -  angle of repose 
 h   -  height of pile in cm 
  r    -  radius of pile in cm 
 
 The powder mixture was allowed to flow through the funnel fixed 
to a stand at definite height (h). The angle of repose was then calculated 
by measuring the height and radius of the heap of powder formed. Care 
was taken to see that the powder particles slip and roll over each other 
through the sides of the funnel. Relationship between angle of repose 
and powder flow property (Debjit Bhowmik et al., 2009). 
TABLE 1: Limits for angle of repose 
ANGLE OF REPOSE POWDER FLOW 
< 25o EXCELLENT 
25-30o GOOD 
30-40o PASSABLE 
>40o VERY POOR 
 
b. Bulk Density (Db): 
It is the ratio of total mass of powder to the bulk volume of powder. It 
was measured by pouring the weighed powder (passed through 
standard sieve # 20) into a measuring cylinder and initial weight was 
noted. This initial volume is called the bulk volume. From this the bulk 
density is calculated according to the formula mentioned below. It is 
expressed in g/ml and is given by (Debjit Bhowmik et al., 2009). 
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Where, 
M  - Mass of the Powder 
Vb -  Bulk volume of the powder 
 
c. Tapped Density: 
It is the ratio of total mass of the powder to the tapped volume of 
the powder. Volume was measured by tapping the powder for 750 times 
and the tapped volume were noted if the difference between these two 
volumes is less than 2%. If it is more than 2%, then tapping is continued 
for 1250 times and tapped volume was noted. Tapping was continued 
until the difference between successive volumes is less than 2 % (in a 
bulk density apparatus). It is expressed in g/ml and is given by (Debjit 
Bhowmik et al., 2009) 
 
Where, 
M - mass of powder 
Vt -  tapped volume of the powder. 
 
d. Percentage of compressibility (or) Carr’s index: 
It indicates powder flow properties. It is expressed in 
percentage and is given as the Following 
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TABLE 2: Relationship between % compressibility and flowability 
 
% 
Compressibility 
 
Flow ability 
5 – 12 Excellent 
12 – 16 Good 
18 – 21 Fair passable 
23 – 35 Poor 
33 – 38 Very poor 
< 40 Very very poor 
 
e.Hausner ratio: 
Hausner ratio is an indirect index of ease of powder flow. It Is calculated by 
the  following formula (Debjit Bhowmik et al., 2009) 
 
 
 
Lower hausner ratio (<1.25) indicates better flow properties than higher ones 
(>1.25). 
 
TABLE 3: Relationship between flow characters and Hausner’s ratio 
 
Flow characters Hausner’s ratio 
Excellent 1.00 – 1.11 
Good 1.1 – 1.18 
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Fair 1.19 – 1.25 
Passable 1.26 – 1.34 
Poor 1.35 – 1.45 
Very poor 1.46 – 1.59 
Very very poor >1.60 
 
IV. FORMULATION  OF LEVOCETIRIZINE HYDROPCHLORIDE 
ORODISPERSIBLE TABLETS 
Using different superdisintegrants 
 Synthetic superdisintegrants 
-Sodium starch glycolate 
-Crospovidone 
 Natural superdisintegrants 
-Hibiscus leaves mucilage 
-Plantgo ovate seed mucilage 
Isolation of mucilage from hibiscus rosasinensis 
The fresh Hibiscus rosasinensis leaves were collected and washed with 
water. The leaves were crushed and soaked in water for 5-6 hours, boiled for 30 
minutes  and left to stand for 1 hour to allow complete release of mucilage into 
water. The mucilage was extracted using a multi layer muslin cloth bag to remove 
marc from the solution. Acetone (in the quantity of three times the volume of 
filtrate) was added to precipitate the mucilage. The mucilage was separated and 
dried in oven at  35oC, collected, grounded passed through a sieve and stored in a 
desicator until use. 
Isolation of mucilage from plantago ovata seeds 
The seeds of plantago ovata were soaked in disilled water for 48hours and 
then boiled for few minutes for complete release of mucilage into water. The 
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material was squeezed through the muslin cloth for filtering and separating out the 
marc. Then an equal volume of acetone was aaded to the filtrate so as to 
precipitate the mucilage. The separated mucilage was dried in an oven at less 
than 60oC, powdered, sieved and stored in a desicator until use (Rajshree 
Panigrahi et al., 2012).  
By direct compression 
All the formulation components other than lubricants and Glidant were 
accurately weighed, passed through 60-mesh sieve and mixed well for 30 min. 
Talc and magnesium stearate were passed through 80-mesh sieve, mixed with 
above blend for 10 min and resultant blend was directly compressed into 
tablets. The amount of all tablet components other than superdisintegrant and 
diluents were kept constant. Round flat tablets of 200 mg weight and 8 mm 
diameter were prepared using 12 station B/D tolling compression machine  by 
direct compression technique.(kalyankar et al., 2015). 
  
V. EVALUATION OF POST COMPRESSION PARAMETERS OF 
LEVOCETIRIZINE HYDROCHLORIDE ORODISPERSIBLE TABLETS 
General appearance 
The general appearance of a tablet, its visual identity and over all 
“elegance” is essential for consumer acceptance. Tablet’s size, shape, colour, 
surface texture, physical flaws and consistency are noted. 
Tablet thickness & diameter: 
Tablet thickness is an important characteristic in reproducing appearance. 
Tablet thickness and diameter can be measured using a simple procedure. 3 
tablets were taken and their thickness and diameter was measured using digital 
Vernier calipers. (Amit Modi et al., 2012). 
Tablet hardness: 
Hardness of tablet is defined as the force applied across the diameter of 
the tablet in the order to break the tablet. The resistance of the tablet to 
chipping, abrasion or breakage under condition of storage transformation and 
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handling before usage depends on its hardness. Hardness of the tablet of each 
formulation was determined using Pfizer hardness tester (Mukesh et al., 2008). 
Uniformity of weight: 
I.P. procedure for uniformity of weight was followed, twenty tablets were 
taken and their weight was determined individually and collectively on a digital 
weighing balance. The average weight of one tablet was determined from the 
collective weight. The weight variation test would be a satisfactory method of 
determining the drug content uniformity (Mukesh et al., 2008). 
 
TABLE 3: I. P. SPECIFICATION FOR UNIFORMITY OF WEIGHT 
 
AVERAGE WEIGHT OF TABLET % DEVIATION 
80mg or Less ± 10 
More than 80mg but less than 250mg ± 7.5 
250mg or more ± 5 
 
Friability 
It is measure of mechanical strength of tablets. Roche Friabilator was 
used to determine the friability by following procedure. A preweighed tablet was 
placed in the Friabilator. Friabilator consist of a plastic chamber that revolves at 
25 rpm, dropping those tablets at a distance of 6 inches with each revolution. 
The tablets were rotated in the Friabilator for at least 4 minutes. At the end of 
test tablets they were disused and reweighed, the loss in the weight of tablet is 
the measure of friability and is expressed in percentage as (Mukesh et al., 
2008) 
   % friability = loss in weight / initial weight × 100 
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Uniformity of drug content: 
 Randomly Ten tablets of formulation were weighed and crushed in 
mortar and powder equivalent to 200mg of levocetirizine hydrochloride was 
weighed and dissolved in phosphate buffer pH 6.8, the volume was made up to 
100ml. From the stock solution 10ml sample was withdrawn and diluted to 
100ml with phosphate buffer Ph 6.8. The absorbance was measured at 
wavelength 231 nm using UV-Visible spectrophotometer. Content uniformity 
was calculated using formula (Amit Modi et al., 2012). 
 
In vitro dissolution studies 
Dissolution rate was studied by using USP type –II apparatus 
(dissolution test apparatus at 50 rpm) using 500 ml phosphate buffer pH 6.8 as 
dissolution medium. Temperature of the dissolution medium was maintained at 
37 ± 0.50C, sample was withdrawn at every 5 min interval and diluted suitably 
and the absorbance of solution was measured by UV spectrophotometer 
method at 231 nm and concentration of the drug is determined from the 
standard calibration. 
 
In vitro release studies details: 
 Apparatus used                         :    USPXXIII dissolution test apparatus  
 Dissolution medium                   :     phosphate buffer pH 6.8           
 Dissolution medium volume      :    500ml 
 Temperature                              :    37 ± 0.50C 
 Speed of paddle                         :    50rpm 
 Sampling intervals                      :    5 min 
 Sample withdraw                        :    10ml 
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 Absorbance measured               :    231nm 
In vitro disintegration time 
The test was carried out on 6 tablets using the apparatus specified in IP 
2010 distilled water at 37OC ± 2OC was used as a disintegration medium and 
the time in seconds taken for the entire tablet to disintegrate completely 
(Shallesh Sharma et al., 2008). 
 
Disintegration time 
 Uncoated tablets : 5 -30 minutes 
 
 Coated tablets     : 1- 2 hours 
 
 Fast dissolving tablets : less than 3 minutes (European 
pharmacopeia) 
 
Water absorption ratio 
A piece of tissue paper folded twice was placed in a small Petri dish containing 
6 ml of water. A tablet was put on the paper and time required for complete wetting 
was measured. Three tablets from each formulation were prepared and standard 
deviation was also determined (Venkateswara et al., 2014). 
 The wetted tablet was then weighed. Water absorption ratio R, was 
determined using equation- 
R = 100×Wa-Wb /Wb 
Where, 
  Wb   =  weight of the tablet before water absorption 
  Wa   =  weight of the tablets after water absorption 
Wetting time 
A piece of tissue paper folded twice was placed in a small petri dish 
containing 6 ml of water or eosin dye and a tablet was put on the paper. The 
time for complete wetting was measured. Three trials for each batch were 
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performed and standard deviation was also determined (venkateswara et al., 
2014). 
 
VI. EFFECT OF SYNTHETIC SUPERDISINTEGRANTS ON RELEASE PROFILE 
OF LEVOCETIRIZINE HCl ORODISPERSIBLE TABLETS 
 
VII. EFFECT OF NATURAL SUPERDISINTEGRANTS ON RELEASE 
PROFILE OF LEVOCETIRIZINE HCl ORODISPERSIBLE TABLETS  
 
VIII. COMPARISION OF DISSOLUION DATA OF LEVOCETIRIZINE HCl 
ORODISPERSIBLE TABLETS CONTAINING DIFFERENT 
SUPERDISINTEGRANTS 
 
IX. BEST FORMULATION SELECTION 
The selection of best formulation is done based on rate of Levocetirizine 
Hydrochloride release from the in vitro dissolution studies. 
 
X. EVALUATION OF SELECTED FORMULATION 
a.Fourier transform Infra-red (FTIR) spectroscopic studies for best 
formulation:  
 Levocetirizine hydrochloride orodispersible (best formulation) are 
subjected to infrared spectroscopic studies as per the procedure already 
discussed in compatibility studies. 
 
b.Differential scanning calorimetry (DSC) for best formulation: 
 Differential scanning calorimetry is used for screening. The specified 
samples is hermetically sealed aluminium pans at temperature 20OC/min 
nitrogen werepurged at 50ml/min and 100ml/min through cooling unit (Himansu 
Chopra et al., 2012).  
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c.Powder X-Ray Diffraction: 
 Powder X-ray diffraction is a unique method in determination of 
crystallinity of a compound. It is used in distinguishing between amorphous and 
crystalline material. Crystal is composed of periodic arrangement of atoms 
whereas amorphous atoms do not possess that periodicity. When there is 
periodic arrangement of atoms, the x-ray will be scattered only in certain 
direction. This will cause high intensity peaks. In amorphous phase, x-rays will 
be scattered in many direction leading to large bump distributed in a wide range 
instead of high intensity narrower peak. 
 
XI. EVALUATION OF INVITRO RELEASE KINETICS 
 To study the invitro release kinetics of the sublingual tablets, data obtained 
from invitro dissolution study were plotted in various kinetics models. 
 1. Zero order release rate kinetics 
 The zero order order release kinetics can be obtained by plotting 
cumulative % drug released Vs time (hours). 
     C=K0 t 
 Where K0 = Zero order constant in conc/time 
         t= time in hours 
2. First order release rate kinetics 
 The graph was plotted as log% cumulative drug remaining Vs time in 
hours. 
     LogC=logC0 – Kt/2.303 
  C0=Initial drug concentration 
  K= First order constant 
  t = Time in hours  
 3. Higuchi kinetics 
 The graph was plotted with % cumulative drug released Vs squre root of 
time. 
     Q = K t1/2 
 Where    K= constant reflecting design variable system 
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           t= time in hours 
 The drug release rate is inversely proportional to the square root of time 
 
4. Hixson and Crowell erosion equation 
 To evaluate the drug release with changes in the surface area and the 
diameter of particles, the data were plotted using the Hixson and crowell erosion 
equation. The graph was plotted by cube root of % drug remaining Vs Time in 
hours. 
     Q0
1/3 – Qt
1/3 = KHC X t 
 Qt = Amount of drug released at time t 
 Q0 = Initial amount of drug  
 KHC = Rate constant for Hixson crowell equation 
 
5. Korsmeyer – peppas equation 
 To evaluate the mechanism of drug release, it was further plotted in 
peppas equation as log cumulative % of drug released Vs log time. 
     Mt / Mα = K t
n 
 Where, Mt / Mα = Fraction of drug release at time t 
   t = release time 
   K= Kinetics constant 
   N=Diffutional exponent indicative of the mechanism of drug                                                  
release 
 If slope values is 0.5 or less, the release mechanism is “Fickian diffusion” 
and if 0.5˂n˂1 it follows “Non Fickian diffusion” (anomalous transport). The drug 
release follows zero order drug release and Non-Fickian case II transport if the 
values is 1. For the values of n higher than 1, the mechanism of drug released 
is regarded as non-fickian case II transport. The model is used to analyse the 
release of pharmaceutical polymeric dosage forms when the release 
mechanism is not known or more than one type of release is involved. 
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XII. STABILITY STUDIES 
The purpose of stability testing is to provide evidence on how quality 
varies with time. The orodispersible tablets are stored under the following 
conditions for a period as prescribed by ICH guidelines for accelerated 
studies. 
Stability of a drug has been defined as the ability of a particular 
formulation, in a specific container, to remain within its physical, chemical, 
therapeutic and toxicological specification. The purpose of stability testing is 
to provide evidence on how the quality of a drug substances or drug product 
varies with time under the influence of a variety of environmental factors such 
as temperature, humidity and light, and enables recommended storage 
conditions, re-test periods and shelf lives to be established. In the present 
studies, stability studies were carried out at 25oC (room temperature) and 
40OC  ± 2OC/ 75 %RH for a specific time period up to 30 days for selected 
formulation. 
Method 
The selected formulations were packed in aluminium boiled paper, they 
were then stored at 25OC (room temperature) and 40OC ± 2OC / 75% RH for 30 
days and evaluated for their hardness, drug content and disintegration time and 
% drug release (Abdul S. Althaf et al., 2011). 
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RESULTS AND DISCUSSION 
I. PREPARATION OF STANDARDCALIBRATION CURVE FOR 
LVOCETIRIZINE HYDROCHLORIDE  
 
Determination of λ-max 
The absorption maximum (λmax) of the Levocetirizine 
hydrochloride was estimated by scanning the drug solution (10µg/ml) 
between 200-400 nm regions on UV spectrophotometer. The obtained 
spectrum showed that the absorption maximum (λmax) was 231nm for 
the levocetirizine hydrochloride. FIG.1 
Calibration of lecocetirizine hydrochloride in phosphate buffer pH 
6.8 
The Standard Calibration curves of levocetirizine hydrochloride were 
prepared using phosphate buffer pH 6.8. The absorbance were measured 
at λmax of 231nm. The correlation coefficient was found to be 0.99978. 
Cilnidipine obeys the beer’s law within the concentration range of (2-
16µg/ml). Calibration plot of levocetirizine hydrochloride in phosphate buffer 
pH 6.8 was shown in FIG.2 and Table 1. 
 
II. COMPATABILTY STUDIES FOR DRUG AND EXCIPIENTS 
 
Fourier Transform Infra-Red Spectroscopic (FT-IR) Studies 
FT-IR spectrum of the pure drug and mixture of pure drug and 
excipients used in the formulation were recorded. The spectra of pure 
levocetirizine hydrochloride showed characteristic peaks at 1743.65 cm-
1(-COOH stetching), 2947.23cm-1 (-CH2 stretching), 758.02 cm-1 (-C-Cl 
stretching). All the above peaks were also observed in the spectra of 
mixture of levocetirizine hydrochloreide  and  excipients with slight 
deviations. This indicating that the drug is stable and there is no drug-
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excipient interaction (Bhaskar Umarji et al., 2012) Fig. 3A, 3B, 3C, 
3D,3E, 3F, 3G, 3H and  3I  . 
III. PREFORMULATION EVALUATION OF POWDER BLEND  
The prepared tablets were evaluated on various parameters such as 
thickness and diameter, hardness, weight variation, friability, uniformity 
content, wetting time, water absorption ratio, In-vitro disintegration time and 
In-vitro dissolution test. The results were summarized in Table 3. 
Angle of repose 
 The angle of repose was used to determine the flow properties of 
powder blend. The angle of repose of the formulations ranged from 27˚29’ 
to 34˚ 32’.The results indicated that the formulations with synthetic 
superdisintegrants  exhibited good flow properties whereas the natural 
superdisintegrants had a passable flow property. The results of angle of 
repose for all the formulations were shown in Table 3 and FIG. 6. 
Bulk density 
 The bulk density is used as an index of the ability of the powder to 
flow. The bulk density of the formulations was in the range of 0.65 – 0.78 
g/ml. The values of bulk density showed that the blend was not tightly 
packed and indicated good flow properties for synthetic super disintegrants  
and passable for natural super disintegrants diluents. The results of bulk 
density for all the formulations were shown in Table 3 and FIG. 7. 
Tapped density 
 The tapped density was used to access the free flowing properties of 
powder blend. The tapped density of the formulations were in the range of 
0.74-0.87 g/cm3.The results indicated that the blends of the formulation had 
good flow properties for synthetic superdisintegrants and passable for 
natural superdisintegrants. The results of tapped density for all the 
formulations were shown in Table 3 and FIG. 8. 
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Carr’s compressibility index 
 The Carr’s compressibility index was used to access the free flowing 
properties of powder blend. The compressibility index of all the formulations 
ranged from 8.693 – 12.985%. The value below 16% has a good flow 
property and good propensity of compression. The results of compressibility 
for all formulations were shown in Table 3 and FIG. 9. 
Hausner’s ratio 
The Hausner’s ratio was an indirect index of ease of powder flow. 
The Hausner’s  ratio of all the formulations ranged from 1.1-1.148. This 
indicates better flow property of blend. The results of Hausner’s ratio for all 
the formulations were shown in Table 3 and FIG.10. 
 
IV. FORMULATION OF LEVOCETIRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS  
The orodispersible tablets of Levocetirizine Hydrochloride was 
prepared by direct compression method using synthetic 
superdisintegrants (sodium starch glycolate and crospovidone) and 
natural superdisintegrants (hibiscus leaves mucilage and plantago ovata 
seed mucilage). The compositions of the different formulation were given 
in Table 2A and 2B. Twelve  Formulations (F1 to F12) were prepared as 
per formula designed. All the tablets were white color and round in shape 
having 8 mm diameter. 
 
V. POST COPMRESSION EVALUATION 
 
a. General appearance 
The tablets were white coloured and round shaped. All tablets 
were elegant in appearance. 
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b. Thickness and diameter 
The thickness and diameter of the formulations were used to 
determine the uniformity of size and shape of the tablets. From the 
results it was found that the thickness of the tablet in all formulation 
was 3.8-4mm and the diameter of the tablet in all formulation was 
8mm.The results indicated that all the formulations had uniform size 
and shape. The results were shown in Table 4A. 
 
c. Hardness 
The hardness of the tablets was used to determine the 
resistance capacity of the tablets to chipping, abrasion or breakage 
under conditions of storage, transportation and handling before 
usage. The hardness of the tablets of all the formulations was found 
to be in the range of 3.53-3.73 kg/cm2. The result indicated that all 
the tablets had a good mechanical strength. The results of the 
hardness for all the formulations were shown in Table 4A. 
 
d. Weight variation test 
The weight variation test was used to ensure the uniformity of the 
tablet in all formulations. The weight of all the tablets from each 
formulation was in the range from 198.51 mg to 200.96 mg. It was found 
all the tablets passed weight variation test, as the percentage weight 
variation was within the acceptable limits of 7.5%. The results were 
shown in Table 4A. 
e. Friability test 
Friability test was measured to ensure the mechanical strength of 
tablet. The results showed that the friability of all the formulation ranged 
from 0.54% to 0.76%. Friability of all the formulation was lesser than 1 
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% which indicated the tablets had a good mechanical resistance. The 
results were shown in Table 4A. 
f.  Uniformity of drug content 
The uniformity content test was used to determine the uniform 
amount of active ingredient present in all formulations. The drug content 
in the content uniformity of all the formulations was found to be in the 
range of 97.60 % - 98.24%. The results indicated all the formulations 
were within the acceptable limits as per USP limits. The results were 
shown in Table 4A. 
 
g. In vitro drug release study 
The dissolution profile range in 30 minutes was 62.03% to 98.31% 
(Table 5A and 5B). The drug release was found to be comparatively less in 
formulation containing natural superdisintegrant (hibiscus leaves mucilage). 
The maximum dissolution drug release rate was observed with the 
formulation containing crospovidone (10mg) as a synthetic 
superdisintegrants.(FIG. 12A, 12B, 12C and 12D) 
This study indicated that synthetic superdisintegrants produce the 
better drug release rate compared to natural superdisintegrants . the 
formulaion containing crospovidone (5%)  was to show dissolution in 
30minutes of dissolution study produced 98.31% which compiled with WHO 
guideline. Many factors contributed for faster drug release rate such as 
rapid disintegration and increased wettability. Among the 12 formulations 
the formulation 5 (F5)  was selected, as a best formulation because of its 
desirable character of low disintegration time, highest drug release, high 
water absorption rate and short wetting time.  
h. In vitro disintegration time 
The in-vitro disintegration time was determined by disintegration test 
apparatus. The results were shown in Table 4B. Formulations F1, F2, 
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F3, F4, F5, F6, F7, F8, F9, F10, F11 and F12 showed the disintegration 
time 52.03, 49.53, 55.46, 42.73, 39.7, 44.3, 61.73, 63.86, 68.26, 65.43, 
70.43 and 71.26 seconds respectively. It was observed that 
Formulation F5containing Crospovidone (5%) disintegrated rapidly in a 
short time (39.7seconds). The results of disintegration of all the tablets 
were found to be lesser than 180 seconds. So all the formulation 
satisfied the criteria of fast dissolving tablets. 
 
i. Water absorption ratio 
The water absorption ratio test was used to ensure the capacity of 
the superdisintegrant and the diluent to absorb the water. The results of 
water absorption ratio of all the formulation were shown in Table 4B. 
Formulations F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11 and F12 
showed the water absorption ratio 58.81%, 61.51%, 70.06%, 81.13%, 
84.87%, 79.99%, 61.32%, 55.39%, 59.87%, 61.17%, 58.46% and 59.65% 
respectively. The results showed that as concentration of superdisintegrant 
increased water absorption ratio was also increased. Formulation F5 
containing crospovidone (5%) as showed highest water absorption ratio 
(84.87%) when compared to other formulations. 
The reason for high water absorption ratio for F5 formulation 
containing Crospovidone quickly wicks water in to the tablet to generate 
volume expansion. Crospovidone uses combination of swelling and wicking. 
j. Wetting time 
Wetting time of the tablet was used to assess the capacity of the 
tablets to disintegrate by swelling in water. All the formulations showed 
quick wetting, this may be due to ability to swelling and also capacity of 
absorption of water. The results of wetting time of all the formulations 
were shown in Table 4B. 
The formulationsF1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11  
and  F12 showed the wetting time, 57.3, 56.5, 61.83, 48.2, 47.3, 51.4, 
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73.63, 72.43, 78.4, 74.2, 81.56 and 83.3 seconds respectively. The 
results indicated that the concentration of superdisintegrant influenced 
the wetting time. Formulation F5 containing crospovidone (5%) showed 
lesser wetting time than other formulations. 
This may be due to fact that superdisintegrant –Crospovidone 
performed its action by the combination of wicking and swelling action. 
Formulation F5 showed shorter wetting time. (Debjit Bhowmik et al., 
2009). 
 
VI. EFFECT OF SYNTHETIC SUPERDISINTEGRANTS ON RELEASE      
PROFILE OF LEVOCETIRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS 
To study the effect of synthetic superdisinegrants on release rate of 
levocetirizine hydrochloride orodispersible tablets, six formulations (F1 to 
F6) were prepared by using sodium starch glycolate and crospovidone as 
superdisintegrant in various concentration (2.5%, 5%, 7.5%) with mannitol 
used as a  diluent. The formulated tablets were subjected to various quality 
tests and the release rates were shown in FIG. 12A and 12B. The 
dissolution data was presented in the Table 5A. The in vitro kinetics was 
presented in the Table 6A. The dissolution rate followed first order kinetics 
as the graph between log% drug unreleased Vs time were found linear. The 
dissolution rate of levocetirizine hydrochloride with organic diluents was 
found better when compared with inorganic diluents. 
VII. EFFECT OF NATURAL SUPERDISINTEGRANTS ON RELEASE 
PROFILE OF  LEVOCETIRIZINE HYDROCHLORIDE ORODISPERSIBLE 
TABLETS 
To study the effect natural superdiintegrants on release rate of 
levocetirizine hydrochloride orodispersible tablets, six formulations (F7 to 
F12) were prepared by using hibiscus leaves mucilage and plantago 
ovata seed mucilage as superdisintegrant in various concentration 
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(2.5%, 5%, 7.5%) with mannitol as a  diluent. The formulated tablets 
were subjected to various quality tests and the release rates were shown 
in FIG. 12C and 12D. The dissolution data was presented in the Table 
5B. The invitro kinetics was presented in the Table 6B. The dissolution 
rate followed first order kinetics as the graph between log% drug 
unreleased Vs time were found linear. The dissolution rate of naural 
superdisintegrants was found lower compared with synthetic 
superdisintegrants. 
VIII. COMPARISION OF DISSOLUTION DATA OF LEVOCETIRIZINE 
HYDROCHLORIDE TABLETS CONTAINING DIFFERENT 
SUPERDISINTEGRANTS 
The tablets prepared with crospovidone showed maximum drug 
release of 98.31% whereas tablets containing sodium starch glycolate, 
plantago ovata seed mucilage and hibiscus leaves mucilage showed 
maximum drug release of 90.11%, 80.43% and 67.32% respectively. 
IX.  SELECTION OF BEST FORMULATION 
Among twelve formulations, the best was selected on the basis of 
lowest disintegration time, rapid drug release profile, higher water 
absorption ratio, short wetting time. Formulation F5 showed lowest 
disintegration time of 39.7 seconds, faster drug release rate of 98.31 %in 
30 minutes, comparatively high water absorption ratio of 84.87% and 
short wetting time of 47.3 seconds. In these parameter would drive the 
F5 formulation as a best formulation. 
X. EVALUATION OF SELECTED FORMULATION 
a.Differential Scanning Calorimetry (DSC) Studies 
Any possible drug polymer interaction can be studied by thermal 
analysis. The DSC thermogram of levocetirizine hydrochloride exhibited 
an sharp endothermic peak at at 218.862oC, which corresponding to its 
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melting temperaure. The thermogram of the final best formulation of 
levocetirizine hydrochloride with other excipients show the existence of 
drug endothermic peak within the range which indicated the absence of 
interaction between the drug and other excipients. The DSC thermogram 
of pure drug and the final best formulation is presented in FIG. 5A and 
5B . 
b. Fourier Transform Infra-Red (FT-IR) Spectroscopic studies 
Infrared spectra of the levocetirizine hydrochloride orodispersible 
tablets showed major peaks at 1739 cm-1, 2947.23 cm-1 and 75 cm-1 
indicated that there was no interaction between the drug and the final 
formulation throughout the preparation of orodispersible tablets. The 
result was shown in FIG. 3J. 
 c. Powder X-Ray Diffraction 
The X-Ray diffracograms of Levocetirizine hydrochloride best 
formulation (F5) showed the characteristic peaks between 2θ of 15o  and 
25o indicated that there ws no interaction between the drug and 
excipients. The result was shown in FIG. 6A and 6B.  
 
XI.  DRUG RELEASE KINETIC MODEL 
In order to describe the kinetics of the release process of drug in 
all formulations, equations such as zero-order and first- order rate 
equations were used. Zero order rate equation describes the system 
where the release rate is independent of the concentrations of the 
dissolved species. While the first- order equation describes the release 
from systems where dissolution rate is dependent on the concentration 
of the dissolving species. It is evident from Table 6A and 6B that the 
drug release process is not zero order in nature. This indicates that the 
dissolution rate of the drug is not independent of the amount of drug 
available for dissolution and diffusion from the matrix. The dissolution 
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data of all formulations when fitted in accordance with the first order 
equation it is evident that a linear relationship was obtained with ‘r’ 
(correlation coefficient) value close to unity and higher than ‘r’ obtained 
from zero order equation for all formulation (table), showing that the 
release is an apparent first order process. This indicates that the amount 
of drug released is dependent on the matrix. 
The obtained from invitro dissolution studies were fitted to zero –
order, first-order and Korsmeyer Peppas equation. The first-order plots 
were found to be fairly linear as indicated by their high regression values. 
To confirm the exact mechanism of drug release, the data were fitted 
according to Korsmeyer Peppas equation: 
Mt/m∞ = k tn 
where mt/m∞ is fraction of drug released, k is kinetic constant, t is 
release time and n is the diffusional exponent for drug release. Peppas 
stated that the above equation could adequately describe the release of 
solutes from slabs, spheres, cylinders and discs, regardless of the 
release mechanism. The value of ‘n’ gives an indication of the release 
mechanism; when n =1, the release rate is independent of time (zero-
order) (case II transport), n = 0.5 for Fickian diffusion and when 0.5 < n 
<1.0, diffusion and non-Fickian transport are implicated. Lastly, when n > 
1.0 super case II transport is apparent. ’n’ is the slope value of log mt/m∞ 
versus log time curve. Slope values (n > 1.0) suggest that the release of 
cilnidipine from orodispersible tablets followed Supercase-II transport 
suggesting that more than one mechanism may be involved in the 
release kinetics. The results were shown in table 6A and 6B. 
 
XII. STABILITY STUDIES 
The formulations F5 was selected for stability studies on the basis 
of their high cumulative % drug release and also results of in vitro 
disintegration time and wetting time. The stability studies carried out at 
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25OC (room temperature) and 40OC/75%RH for the best formulations up 
to 30 days. In 15 day time interval, the tablets were analyzed for 
hardness, drug content uniformity, invitro disintegration time, % drug 
release up to 30 days. The formulation showed not much variation in any 
parameter. The results are tabulated in Table 7A and 7B. From these 
results it was concluded that, formulation F5 (crospovidone 5%) was 
stable and retained its original properties.  
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TABLE 1:  CALIBRATION OF LEVOCETRIZINE HYDROCHLORIDE WITH 
PHOSPHATE BUFFER pH 6.8 
S.NO CONCENTRATION (µg/ml) ABSORBANCE ±SD 
1 
 
4 
 
0.134 ± 0.015 
 
2 8 
 
0.229 ± 0.0013 
 
3 12 
 
0.341 ± 0.006 
 
4 16 
 
0.456 ± 0.009 
 
5 20 
 
0.569 ± 0.010 
 
6   24 
 
0.685 ± 0.006 
 
7 28 
 
0.810 ± 0.020 
 
8 32 
 
0.912 ± 0.006 
 
 
N= 3 *       REGRESSION VALUE =0.99928±0.0003 
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TABLE 2  A: LEVOCETRIZINE HYDROCHLORIDE ORODISPERSIBLE 
TABLETS (F1 TO F6) 
                                         
 
INGREDIENTS 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
Levocetrizine 
hydrochloride 
(Small) 
 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
Microcrystalline 
Cellulose 
 
 
30 
 
30 
 
30 
 
30 
 
30 
 
30 
 
Sodium starch 
Glycolate 
 
 
5 
 
10 
 
15 
 
- 
 
- 
 
- 
Crospovidone 
 
 
- 
 
- 
 
- 
 
5 
 
10 
 
15 
Mannitol 
 
148 
 
143 
 
138 
 
148 
 
143 
 
138 
Saccharin 
Sodium 
 
2 2 2 2 2 2 
Aerosil 
 
2 
 
 
2 
 
2 
 
2 
 
2 
 
2 
Magnesium 
stearate 
1 1 1 1 1 1 
Talc 
 
2 
 
 
2 
 
2 
 
2 
 
2 
 
2 
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TABLE 2 B: LEVOCETRIZINE HYDROCHLORIDE ORODISPERSIBLE  
TABLETS (F7 TO F12) 
                                   
 
INGREDIENTS 
 
F7 
 
F8 
 
F9 
 
F10 
 
F11 
 
F12 
 
Levocetrizine 
hydrochloride 
 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
 
10 
 
Microcrystalline 
Cellulose 
 
 
30 
 
30 
 
30 
 
30 
 
30 
 
30 
 Hibiscus leaves 
mucilage 
 
 
5 
 
10 
 
15 
 
- 
 
- 
 
- 
Plantago ovata 
seeds mucilage  
 
 
- 
 
- 
 
- 
 
5 
 
10 
 
15 
Mannitol 
 
148 
 
143 
 
138 
 
148 
 
143 
 
138 
Saccharin 
Sodium 
 
2 2 2 2 2 2 
Aerosil 
 
2 
 
 
2 
 
2 
 
2 
 
2 
 
2 
Magnesium 
stearate 
1 1 1 1 1 1 
Talc 
 
2 
 
 
2 
 
2 
 
2 
 
2 
 
2 
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TABLE 3: PRE COMPRESSION EVALUATION STUDY FOR LEVOCETRIZINE    
        HYDROCHLORIDE ORODISPERSIBLE TABLETS FORMULATIONS  
Formulation 
code 
Angle of 
repose 
Bulk 
density 
Tapped 
density 
Percentage of 
compressibility 
Hausner’s 
Ratio 
F1 28.92±0.718 0.78±0.015 0.85±0.024 8.693±0.880 1.095±0.104 
F2 30.02±0.392 0.78±0.010 0.87±0.007 9.611±0.639 1.100±0.007 
F3 30.86±0.704 0.77±0.015 0.86±0.006 9.565±1.718 1.115±0.014 
F4 30.04±0.465 0.77±0.015 0.86±0.006 11.128±3.023 1.126±0.038 
F5 27.29±0.801 0.78±0.010 0.86±0.012 9.201±0.098 1.101±0.001 
F6 28.58±0.402 0.77±0.015 0.87±0.019 11.211±0.768 1.120±0.009 
F7` 34.32±0.573 0.67±0.012 0.74±0.019 10.351±0.761 1.115±0.009 
F8 32.02±1.103 0.65±0.015 0.75±0.019 10.483±0.678 1.117±0.008 
F9 31.31±1.009 0.68±0.018 0.75±0.009 11.555±1.367 1.130±0.017 
F10 30.86±0.704 0.75±0.014 0.86±0.018 11.847±1.869 1.134±0.024 
F11 33.21±0.903 0.74±0.013 0.83±0.006 12.985±1.129 1.148±0.015 
F12 33.04±1.518 0.75±0.018 0.83±0.023 11.154±0.285 1.125±0.004 
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TABLE 4A: POST COMPRESSION EVALUATION STUDY FOR 
LEVOCETRIZINE  HYDROCHLORIDE ORODISPERSIBLE TABLETS 
FORMULATION 
 
 
 
F.cod
e 
Weight 
uniformity 
test  ± SD 
Drug content 
in 
percentage ± 
SD 
Hardness(kg 
/ cm2) ± SD 
Thickness 
(mm) ± SD 
Friability 
±SD 
F1 198.51±0.341 97.60±0.805 3.56±0.115 3.96±0.057 0.630±0.043 
F2 198.68±0.326 98.10±0.254 3.7±0.1 4±0.1 0.63±0.014 
F3 199.01±0.577 97.81±0.44 3.7±0.1 4.06±0.057 0.58±0.126 
F4 199.01±0.459 98.24±0.435 3.66±0.152 3.96±0.057 0.55±0.024 
F5 199.07±0.610 98.24±0.435 3.53±0.057 4±0.1 0.55±0.015 
F6 199.28±0.583 98.1±0.502 3.6±0.1 4.03±0.152 0.54±0.039 
F7 200.19±0.468 98.1±0.502 3.7±0.1 3.93±0.057 0.66±0.045 
F8 200.96±0.482 98.24±0.435 3.66±0.115 3.9±0.1 0.68±0.010 
F9 199.96±1.531 97.66±0.906 3.66±0.057 3.96±0.057 0.74±0.035 
F10 200.19±0.458 97.81±0.44 3.7±0.1 3.93±0.152 0.76±0.011 
F11 200.37±0.483 98.24±0.435  3.63±0.152 3.9±0.1 0.70±0.019 
F12 199.55±0.704 98.10±0.254 3.73±0.057 3.83±0.057 0.67±0.063 
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TABLE 4B: POST COMPRESSION EVALUATION STUDY FOR 
LEVOCETIRIZINE HYDROCHLORIDE ORODISPERSIBLE TABLETS 
 
FORMULATION 
CODE 
Disintegration 
time in sec ±SD 
Water 
Absorption ratio 
in % ± SD 
Wetting Time in 
sec ± SD 
F1 52.03±1.250 58.81±0.712 57.3±1.951 
F2 49.53±0.737 61.51±0.793 56.5±1.752 
F3 55.46±1.083 70.06±1.582 61.83±1.550 
F4 42.46±0.757 81.13±2.041 48.2±0.6 
F5 39.7±0.458 84.87±2.914 47.3±0.953 
F6 44.3±0.818 79.99±3.208 51.4±1.081 
F7 61.73±2.247 61.3±3.746 73.63±3.156 
F8 63.86±1.222 55.39±1.030 72.43±2.020 
F9 68.26±2.550 59.87±1.736 78.4±4.150 
F10 65.43±1.205 61.17±2.540 74.2±1.552 
F11 70.43±1.724 58.46±2.15 81.56±2.909 
F12 71.26±1.890 59.65±0.905 83.3±3.051 
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TABLE 5A: Invitro RELEASE PROFILE OF LEVOCETRIZINE 
HYDROCHLORIDE ORODISPERSIBLE TABLETS 
 
FORM
ULA 
TION 
CODE 
5TH MINUTE 10TH 
MINUTE 
15TH 
MINUTE 
20TH 
MINUTE 
25TH 
MINUTE 
30TH 
MINUTE 
F1 77.23 ± 
0.446 
78.94 ± 
0.258 
80.73 ± 
0.682 
82.22 ± 
1.182 
84.01 ± 
1.182 
85.94 ± 
0.930 
F2 77.97 ± 
0.257 
80.13 ± 
0.258 
82.52 ± 
0.516 
85.05 ± 
0.258 
87.73 ± 
0.258 
90.11 ± 
0.6826 
F3 75.14 ± 
0.681 
77.30 ± 
0.893 
78.94 ± 
0.930 
80.88 ± 
1.182 
82.67 ± 
0.893 
84.31 ± 
0.516 
F4 81.84 ± 
0.681 
84.31 ± 
0.930 
86.69 ± 
0.774 
89.07 ± 
1.032 
91.60 
±1.182 
94.14 ± 
0.930 
F5 84.82 ± 
0.446 
87.43 ± 
0.682 
90.11 ± 
0.682 
92.50 ± 
0.446 
95.33 ± 
0.516 
98.31 ± 
0.446 
F6 81.72 ± 
0.406 
84.01 ± 
0.446 
86.24 ± 
0.774 
88.92 ± 
1.182 
91.60 ± 
1.182 
94.43 ± 
0.930 
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TABLE 5B: IN-VITRO RELEASE PROFILE OF LECOCETIRIZINE 
HYDROCHLORIDE ORODISPERSIBLE TABLETS 
 
 
 
F.COD
E 5
TH 
MINUTE 
10TH 
MINUTE 
15TH 
MINUTE 
20TH 
MINUTE 
25TH 
MINUTE 
30TH 
MINUTE 
F7 50.03 
±1.975 
53.17 
±0.446 
55.11 
±0.258 
57.34 
±0.682 
59.73 
±0.930 
62.11 
±0.895 
F8 54.46 
±0.446 
56.60 
±0.258 
59.43 
±0.446 
61.37 
±0.930 
64.49 
±1.365 
67.32 
±1.436 
F9 51.488 
±0.681 
53.17 
±0.893 
55.71 
±1.569 
57.79 
±1.569 
66.03 
±1.124 
62.03 
±1.914 
F10 66.66 
±0.681 
69.11 
±0.930 
71.94 
±1.182 
74.47 
±1.365 
76.86 
±1.340 
79.245 
±1.365 
F11 69.79 
±0.681 
72.24 
±0.930 
74.03 
±0.258 
76.56 
±0.258 
78.50 
±0.258 
80.43 
±0.446 
F12 
 
68.450 
±0.681 
70.90 
±1.124 
73.13 
±1.56 
75.52 
±2.047 
77.45 
±1.806 
79.39 
±1.860 
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TABLE 6A : IN-VITRO RELEASE KINETICS DATA OF LEVOCETIRIZINE 
HYDROCHLORIDE 
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TABLE 6B : IN-VITRO RELEASE KINETICS DATA OF LEVOCETIRIZINE 
HYDROCHLORIDE 
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TABLE 7A : STABILITY FOR THE BEST FORMULATION (F5) 
 
 
TEMPER
ATURE 
 
 
DAYS 
 
 
DRUG 
CONTENT 
(%) 
 
 
HARD 
NESS IN 
kg / cm2 
 
 
DISINTEGRA
RATION TIME 
 
 
DRUG 
RELEASE 
(%) 
 
 
 
25º C 
 
15 
 
98.19 
 
3.65 
 
40.6 
 
98.16 
 
30 
 
98.1 
 
3.7 
 
41.2 
 
97.12 
 
 
40º C / 75 
% RH 
 
15 
 
97.8 
 
3.8 
 
41.8 
 
96.97 
 
30 
 
97.66 
 
3.84 
 
42.3 
 
95.18 
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TABLE 7B :In vitro RELEASE OF STABILITY STUDIES FOR THE 
BEST FORMULATION (F5) 
 
 
TIME 
IN 
MINS 
 
 
CONTROL 
 
25º C 
 
40º C / 75 % RH 
 
15TH DAY 
 
30TH DAY 
 
15TH DAY 
 
30TH DAY 
 
5 
 
84.82 
±0.446 
 
85.89 ± 
1.907 
 
83.92±1.609 
 
82.72 ± 0.406 
 
81.72 
±0.406 
 
10 
 
87.43 
±0.682 
 
88.48 ± 
2.047 
 
86.39±1.806 
 
84.57 ± 0.636 
 
84.57 
±0.636 
 
15 
 
90.11 
±0.682 
 
90.864 
±1.569 
 
88.48±2.047 
 
86.544±0.258 
 
86.54 
±0.258 
 
20 
 
92.50 
±0.446 
 
93.39 ±1.947 
 
91.46 1.806 
 
90.11±0.682 
 
89.07  
± 0.930 
 
25 
 
95.33 
±0.516 
 
96.07 ±1.611 
 
94.58±1.806 
 
94.43±1.290 
 
91.758 
±0.930 
 
30 
 
98.31 
±0.446 
 
98.16±0.258 
 
97.12±1.691 
 
96.97±1.154 
 
95.18 
±0.446 
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FIG.1: DETERMINATION OF λmax OF LEVOCETIRIZINE HYDROCHLORIDE 
 
FIG.2: CALIBRATION OF LEVOCETIRIZINE HYDROCHLORIDE 
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FIG.3A : FT-IR SPECTRUM – LEVOCETIRIZINE HYDROCHLORIDE 
 
FIG.3B : FT-IR SPECTRUM - CROSSPOVIDONE 
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FIG.3C : FT-IR SPECTRUM – SODIUM STARCH GLYCOLATE 
 
 
FIG.3D : FT-IR SPECTRUM -  MICROCRYSTALLINE CELLULOSE 
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FIG.3E :FT-IR  SPECTRUM – AEROSIL 
 
 
FIG.3F : FT-IR SPECTRUM – DRUG WITH CROSPOVIDONE 
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FIG.3G : FT-IR SPECTRUM – DRUG WITH SODIUM STARCH GLYCOLATE 
 
FIG.3H : FT-T-IR SPECTRUM – DRUG WITH HIBISCUS LEAVES DRIED 
MUCILAGE 
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FIG.3I : FT-IR SPECTRUM – DRUG WITH PLANAGO OVATA DRIED 
MUCILAGE 
 
FIG.3J : FT-IR SPECTRUM – BEST FORMULATION 
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FIG.4A : XRD OF PURE DRUG 
 
 
FIG.4B : XRD OF BEST FORMULATION 
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FIG 5A : DSC OF PURE DRUG 
 
 
FIG.5 B: DSC OF BEST FORMULATION (F5) 
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FIG.6 : ANGLE OF REPOSE OF ALL FORMULATIONS (F1-F12) 
                  
 
FIG.7 : BULK DENSITY OF ALL FORMULATIONS (F1-F12)   
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FIG.8 : TAPPED DENSITY OF ALL FORMULATIONS (F1-F12) 
 
FIG.9 : COMPRESSIBILITY INDEX OF ALL FORMULATIONS (F1-F12) 
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FIG. 10 : HAUSNER’S RATIO OF ALL FORMULATIONS (F1-F12) 
 
 
 
FIG.11 : DRUG CONTENT FOR ALL FORMULATIONS (F1-F12) 
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FIG.12A : IN-VITRO RELEASE OF LEVOCETIRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS (F1-F3)   
 
 
 
 
FIG.12B : IN-VITRO RELEASE OF LEVOCETIRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS (F4-F6)   
 
0
10
20
30
40
50
60
70
80
90
100
0 5 10 15 20 25 30 35
C
u
m
u
la
iv
e
 %
 d
ru
g
 r
e
le
a
s
e
Time in minutes
F1
F2
F3
0
20
40
60
80
100
120
0 5 10 15 20 25 30 35
C
u
m
u
la
ti
v
e
 %
 d
ru
g
 r
e
le
a
s
e
Time in minutes
F4
F5
F6
CHAPTER IX                                               RESULTS AND DISCUSSION 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 137 
 
 
FIG.12C :  IN-VITRO RELEASE OF LEVOCETIRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS (F7-F9)   
 
 
 
FIG.12D : IN-VITRO RELEASE OF LEVOCETIRIZINE HYDROCHLORIDE 
ORODISPERSIBLE TABLETS (F10-F12)  
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FIG.13A : COMPARISON OF IN-VITRO ZERO ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING SODIUM STARCH GLYCOLATE 
 
 
FIG.13B : COMPARISON OF IN-VITRO ZERO ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING CROSPOVIDONE 
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FIG.13C : COMPARISON OF IN-VITRO ZERO ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING HIBISCUS LEAVES MUCILAGE 
 
 
 
 
FIG.13D : COMPARISON OF IN-VITRO ZERO ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING PLANTAGO OVATA SEED MUCILAGE 
 
 
0
10
20
30
40
50
60
70
80
0 5 10 15 20 25 30 35
C
u
m
u
la
ti
v
e
 %
 d
ru
g
 r
e
le
a
s
e
Time in minutes
F7
F8
F9
0
10
20
30
40
50
60
70
80
90
0 10 20 30 40
C
u
m
u
la
ti
v
e
 %
 d
ru
g
 r
e
le
a
s
e
Time in minutes
F10
F11
F12
CHAPTER IX                                               RESULTS AND DISCUSSION 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 140 
 
FIG.14A : COMPARISON OF IN-VITRO FIRST ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING SODIUM STARCH GLYCOLATE 
 
 
 
 
FIG.14B : COMPARISON OF IN-VITRO FIRST ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING CROSPOVIDONE 
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FIG.14C : COMPARISON OF IN-VITRO FIRST ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING HIBISCUS LEAVES MUCILAGE 
 
 
 
 
FIG.14D : COMPARISON OF IN-VITRO FIRST ORDER RELEASE KINETICS 
FOR FPRMULATION CONTAINING PLANTAGO OVATA SEED MUCILAGE 
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FIG.15A : COMPARISON OF IN-VITRO HIGUCHI MODEL RELEASE KINETICS 
OF FORMULATION CONTAINING SODIUM STARCH GLYCOLATE 
 
 
 
FIG.15B : COMPARISON OF IN-VITRO HIGUCHI MODEL RELEASE KINETICS 
OF FORMULATION CONTAINING CROSPOVIDON
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FIG.15C : COMPARISON OF IN-VITRO HIGUCHI MODEL RELEASE KINETICS 
OF FORMULATION CONTAINING HIBISCUS LEAVES MUCILAGE 
 
 
 
 
FIG.15D : COMPARISON OF IN-VITRO HIGUCHI MODEL RELEASE KINETICS 
OF FORMULATION CONTAINING PLANTAGO OVATA SEED MUCILAGE 
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FIG.16A : COMPARISON OF IN-VITRO KORSMEYER PEPPAS MODEL 
RELEASE KINETIC OF FORMULATION CONTAINING SODIUM STARCH 
GLYCOLATE 
 
 
 
 
FIG.16B : COMPARISON OF IN-VITRO KORSMEYER PEPPAS MODEL 
RELEASE KINETIC OF FORMULATION CONTAINING CROSPOVIDONE 
 
1.87
1.88
1.89
1.9
1.91
1.92
1.93
1.94
1.95
1.96
0 0.5 1 1.5 2
Lo
g 
cu
m
u
la
ti
ve
 %
 d
ru
g 
re
le
as
e
LOG TIME IN MINUTES
F1
F2
F3
1.9
1.91
1.92
1.93
1.94
1.95
1.96
1.97
1.98
1.99
2
0 0.5 1 1.5 2
lo
g
 c
u
m
u
la
ti
v
e
 %
 d
ru
g
 r
e
le
a
s
e
log time in minutes
F4
F5
F6
CHAPTER IX                                               RESULTS AND DISCUSSION 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 145 
 
 
FIG.16C : COMPARISON OF IN-VITRO KORSMEYER PEPPAS MODEL 
RELEASEKINETIC OF FORMULATION CONTAINING HIBISCUS LEAVES 
MUCILAGE 
 
 
FIG.16D : COMPARISON OF IN-VITRO KORSMEYER PEPPAS MODEL 
RELEASE KINETIC OF FORMULATION CONTAINING PLANTAGO OVATA 
SEED MUCILAGE 
 
 
1.68
1.7
1.72
1.74
1.76
1.78
1.8
1.82
1.84
0 0.5 1 1.5 2
lo
g
 c
u
m
u
la
ti
v
e
 %
 d
ru
g
 r
e
le
a
s
e
log time in minutes
F7
F8
F9
1.81
1.82
1.83
1.84
1.85
1.86
1.87
1.88
1.89
1.9
1.91
0 0.5 1 1.5 2
L
o
g
 c
u
m
u
la
ti
v
e
 %
 d
ru
g
 r
e
le
a
s
e
Log time in minutes
F10
F11
F12
CHAPTER IX                                               RESULTS AND DISCUSSION 
 
Dept. of Pharmaceutics, College of Pharmacy, MMC, Madurai. Page 146 
 
FIG.17A : COMPARISON OF IN-VITRO HIXSON CROWELL MODEL RELEASE 
KINETICS FOR FORMULATIONS CONTAINING SODIUM STARCH 
GLYCOLATE 
 
 
 
 
FIG.17B : COMPARISON OF IN-VITRO HIXSON CROWELL MODEL 
RELEASE KINETICS FOR FORMULATIONS CONTAINING CROSPOVIDONE 
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FIG.17C : COMPARISON OF IN-VITRO HIXSON CROWELL MODEL RELEASE 
KINETICS FOR FORMULATIONS CONTAINING HIBISCUS LEAVES 
MUCILAGE 
 
 
 
FIG.17D : COMPARISON OF IN-VITRO HIXSON CROWELL MODEL RELEASE 
KINETICS FOR FORMULATIONS CONTAINING PLANTAGO OVATA SEED 
MUCILAGE 
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SUMMARY AND CONCLUSION 
 
 Aim of this study was to prepare Levocetirizine Hydrochloride  
orodispersible tablets using different synthetic and natural 
superdisintegrants  and to compare the effect of different 
superdisintegrants on the release profile of the formulation. 
 The results of Fourier Transmission Infra- Red spectroscopy confirmed 
that the drug and excipients were compatible with each other and were 
devoid of interactions. 
 The results of precompression studies like angle of repose, bulk density, 
tapped density, compressibility index and Hausner’s ratio reveals that 
the prepared powder blends of formulations possess good flow 
properties with synthetic superdisintegrants and passable flow property 
with natural superdisintegrants. 
 The orodispersible tablets are prepared by direct compression 
technique using superdisinegrants in different concentration (2.5 %, 5% 
and 7.5%), mannitol as bulking material, MCC as a binder,  saccharin 
sodium as a sweetening agent . 
 The prepared tablets were subjected to post compression evaluations 
and the results indicated that the hardness, thickness, wetting time and 
water absorption ratio of the tablets prepared from the synthetic 
superdisintegrant (Crospovidone) were better when compared with the 
other formulations. All the tablets were of uniform size and shape with 
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good resistance against mechanical damage. 
 The tablets of all formulations contains uniform amount of drug, which 
ensures content uniformity for tablets of all formulations. 
 The tablets were within the limits of weight variation test, which in turn 
indicate uniform distribution of contents of the powder blends of each 
formulations. 
 The friability of all the tablets was found to be ˂ 1%, which indicates the 
good mechanical resistance. 
 The tablets of best formulations F5 containing 5% crospovidone as 
superdisintegrant was found to have minimum wetting time and 
maximum water absorption ratio which is the desired characteristic of 
orodispersible tablets, which enabled faster disintegration of tablets. 
 Among all the formulations, the best formulation was selected on the 
basis of lowest disintegration time, rapid drug release profile, higher 
water absorption ratio, short wetting time. Formulation F5 showed 
lowest disintegration time of 39.7 seconds, faster drug release rate of 
98.31% in 30 minutes, comparatively high water absorption ratio of 
84.87%, short wetting time of 47.3 seconds and minimum chemicals 
composition. In those parameter would drive the F5 formulation as a 
best comparatively. 
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CONCLUSION 
 Orodispersible tablets of Levocetrizine Hydrochloride tabltes 
prepared by direct compression technique containing synthetic 
superdisintegrants crospovidone (5%) was found to be better disintegration 
property because of its combination effect of swelling and wicking and 
showed best in-vitro dissolution profile than the formulations containing  
natural superdisintegrants (hibiscus leaves dried mucilage and plantago 
ovata seed mucilage). Hence, it can be concluded that using a 
crospovidone can be used as a first choice fof superdisintegrant for the 
formation of orodispersible tablets. 
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